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Pericellular matrix (PCM) is a hyaluronan rich polymer matrix anchored to the outer cell 
membrane surface. Negatively charged bottlebrush proteoglycans also play an important role in 
the matrix giving it its structure. In the past decade, it has been increasingly appreciated that this 
often microns-thick cell coat is involved in regulating a range of key physiological processes, 
including proliferation, migration, synaptogenesis, and wound healing.  How the PCM impacts 
these processes is not well understood, but it is likely in part via physical and/or physiochemical 
processes, resulting from the bulky size and high negative charge of hyaluronan and its 
associated proteoglycans. This thesis work introduces new methods to quantify and probe the 
physical function of the PCM, and addresses two fundamental biophysical questions (i) how the 
PCM impacts transport of objects to the surface and (ii) whether surface-associated hyaluronan 
matrix mechanically regulates cell adhesion.   
A detailed picture of the in vitro PCM microstructure and its impact on the transport of 
molecules and particles to the cell surface is reported for the first time. The work shows that 
particles 40 nm and larger are significantly impacted by the PCM, which acts to filter and reduce 
the number reaching the surface in a size-dependent fashion – a consequence of the decreasing 
pore size of the PCM towards the cell surface. Molecular accessibility to the cell is less impacted 
unless the species is positively charged, in which case studies show that it sequesters strongly 
within the PCM, binding to the negatively-charged bottlebrush proteoglycans. Studies with 
exogenous proteoglycans demonstrate opportunities to modify the thickness and pore size of the 
sieve-like PCM. Addition of proteoglycan into the matrix extends the matrix’s thickness and 
decreases its pore size. Different concentrations of exogenous proteoglycan provide the ability to 
tune the matrix reach and tightness. 
Mechanical quantification of cell adhesion strength versus hyaluronan patches at the cell 




studies with interferometric microscopy reveal that HA increases the roughness of the cell 
interface at the substrate, reducing contact, potentially weakening adhesion. The outcome of 
these detailed studies strongly imply that the role of cell-surface associated hyaluronan in vivo 
deserves much more attention than previously garnered. The PCM acts as a gatekeeper in 
modifying what reaches and adheres to the cell surface – two processes fundamental in the 









The negatively charged polysaccharide hyaluronan (HA) is found throughout the natural 
world, including in vertebrates, algae, mollusks (1) and a subset of microbes. HA is ubiquitous in 
vertebrates playing various roles in many different tissues ranging from the brain to joints to the 
eye to connective tissue. Three transmembrane proteins called hyaluronan synthases (HAS: 
HAS1, HAS2, HAS3) are responsible for synthesizing and extruding HA through the plasma 
membrane in vertebrates. The size of the HA depends on the synthase, where HAS2 produces 
the highest molecular mass products. Studies have demonstrated that HA is required for normal 
development and has several therapeutic functions (2–6). For example, in embryonic 
morphogenesis, deletion of HAS2 in mouse embryos abrogates cardiac morphogenesis and 
causes the embryo to die during mid-gestation (7, 8). Furthermore, HA expression is correlated 
with fundamental processes as broad cell proliferation and migration, synaptogenesis, 
inflammation, cancer metastasis, and wound healing.  
 Hyaluronan in vertebrates can be found in three different contexts: bodily fluids (synovial 
fluid (9, 10), vitreous humor (11)), extracellular matrix (ECM)(12, 13), and pericellular matrix 
(PCM) (14). The focus of this thesis is the pericellular matrix (PCM), a robust polymer matrix that 
is grafted on the membrane of many cells (see Figure 1).  The main components of this extended, 
often microns-thick cell coat are the polymer hyaluronan (HA), hyaluronan-binding bottlebrush-
shaped chondroitin sulfate proteoglycans (CSPG), e.g. versican or aggrecan, and HA surface 
receptors, such as CD44 (2). The PCM’s components are ubiquitous, and its appearance in 
diverse biological contexts, suggest that there is no single defining function for the PCM, but rather 





Figure 1.1: PCM visualized as the exclusion region around the cell without particle presence. (a) 
Rat’s chondrocyte cell, RCJ-P (b) Human prostate cancer cell, PC3 (c) Human breast cancer cell, 




tissues. Previous work has shown that it is involved in fundamental biophysical processes such 
as cell adhesion, migration, and proliferation (3-6).  The role of the PCM in human health remains 
to be fully explored but there is mounting evidence to suggest that it is involved in the onset and 
progression of cancer (7, 8), wound healing (9), and infertility (10). 
The role of surface bound hyaluronan (PCM) is generally not well understood, yet it is 
abundant in the body. The fact that the PCM is fundamentally a cell-regulated interface between 
the cell and its exterior, positions the cell coat to play a gatekeeper role in negotiating the 
integration of cells into tissues as well as what passes to and from the cell surface. The magnitude 
and importance of PCM function is unclear, but by its very nature and presence, it is logical that 
the HA-bottlebrush proteoglycan matrix must play an integrative role with other surface adhesion 




of this, already verified, is synaptogenesis, where a PCM comprised of hyaluronan and neurocan 
suppresses formation of new synapses and stabilizes established synapses (15). 
Historically the role of PCM has been neglected or underappreciated for several reasons. 
The first is that its extreme high hydration makes it impossible to see in bright field microscopy 
and fixation procedures destroy the extended matrix. Therefore, until recently the tools to 
characterize the PCM were crude and limited. Many researchers were not even aware that such 
a construct might extend at least a few hundred nanometers if not microns from cell surfaces in 
their in vitro cell culture. Second, any topic that involves glycobiology has generally been 
considered difficult and few researchers were involved (16, 17). And finally, even for those 
researchers interested in and studying PCM, limited biophysical tools existed to probe and 
investigate the mechanisms behind PCM biology.  A consequence of the state of the field is that 
there are numerous very interesting questions to be pursued if one can provide a few tools to 
characterize both the PCM and the underlying biology.  
This thesis represents one of the first systematic efforts to date to probe the microstructure 
and mechanics of the PCM. In particular, our efforts in the lab throughout the duration of this 
thesis have been primarily focused on characterizing the physical impact of PCM on the two most 
obvious possible processes that the cell coat might have: (i) passage of objects to and from the 
surface and (ii) the mechanics of cell adhesion. 
The remaining of this thesis will be presented in seven chapters. Chapter 2 will provide 
additional background and context, in particular providing an overview of the literature regarding 
what is known about the correlation of hyaluronan expression with cell adhesion-dependent 
processes.  In chapter 3, I present a novel approach to quantify the spatial varying pore size of 
the pericellular matrix and provide a deeper understanding of the PCM structure. Chapter 4 
introduces various biophysical techniques and demonstrates the ability to tune the accessibility 




strength, the force required to detach cells from the substrate, changes with various HA conditions 
and provides evidence of the mechanical impact of the matrix on focal adhesions and the overall 
adhesions state of a cell. Chapter 6 expands the adhesion results to another possibility, 
chondroitin sulfate (CS) mediated adhesion. Chapter 7 summarizes our nascent but promising 
efforts to characterize the HA matrix during cell migration. Finally, chapter 8 concludes with 
summary of the results, and presents an outlook of the exciting questions and directions that can 

















2.1 Hyaluronan (HA) 
HA is a long linear polysaccharide consisting of a repeating disaccharide unit. The 
disaccharide in HA is composed of D-glucuronic acid (GlcUA) and D-N-acetylglucosamine 
(GlcNAc). Each disaccharide is about 1 nm long and 0.5 nm wide (18). The carboxyl group on the 
monomer makes HA a negatively charged at physiological pH (13, 19). HA is synthesized at 
plasma membrane by hyaluronan synthase (HAS) and mostly exists in extracellular regions. HA 
is among the largest polysaccharides in nature. HA molecules can have up to 25, 000 
disaccharide residues, corresponding to 9.5 MDa in molecular weight and 25 μm in length. 
Measured in 0.15M NaCl at 37 °C using multi-angle light scattering, the radius of gyration Rg of 
HA of molecular weight ranging from 40 kDa to 5.5 MDa are about 15 nm to 286 nm, and 
persistence length of HA is estimated to be 7.5 nm (20). HA behaves as a stiffened random coil 
and exhibits non-Newtonian rheology properties which are heavily influenced by both HA 
concentration and length (21). Partially due to the length-dependent rheological properties, the 
biological functions of HA are strongly depending upon its length (22). Long HA polymers are 
space filling, anti-angiogenic, and immunosuppressive and that regulate differentiation, possibly 
by suppressing cell-cell interactions; medium length hyaluronan chain are involved in ovulation, 
embryogenesis, and wound repair; short HA fragments are inflammatory (23), immune-
stimulatory, and angiogenic; HA oligomers made of a few disaccharide residues are antiapoptotic 
and inducers of heat shock proteins (24). With its broad biological functions, HA is used in an 
increasing number of applications including osteoarthritis, wound healing, ophthalmic surgery, 




2.2 HA binding proteins 
Inside the extracellular matrix (ECM) there are abundant of glycosaminoglycan (GAG), 
which are long unbranched polysaccharides consisting of a repeating disaccharide unit. They do 
not normally occur as free chains in vivo. They usually form proteoglycans, which are the GAG 
chains linked to a protein (25). There are different types of proteoglycans depending on the 
different GAG chains and protein combinations. A specific group of proteoglycans consisting of a 
protein core and chondroitin sulfate side chains are therefore known as chondroitin sulfate 
proteoglycan (CSPG). They are known to be structural components of various human tissues, 
including cartilage and involved in certain cell physiological processes, such as cell migration, cell 
growth and interaction with other ECM constituents (26). When the hydrophilic GAG chains 
covalently bound and arranged onto the protein backbones to form a bottlebrush shape, they are 
identified as bottlebrush CSPGs, also known as lecticans or hyalectans. Four members are in the 
lectican family: aggrecan is a major component in cartilage (27); versican is widely expressed in 
connective tissues including vascular smooth muscle, skin epithelial cells and the cells of central 
and peripheral nervous system (28); neurocan and brevican are largely restricted to neural tissues 
(29). All hyalectins contain a common HA-binding domain (G1) that allows them to aggregate 
densely along HA, nearly permanently when reinforced by an additional protein called link protein 
(30). The key physical characteristics of the bottlebrush proteoglycans stem from a second 
domain (G2) that contains a dense region of highly-sulfated glycosaminoglycans (GAGs). The 
third and last domain (G3) is smaller and consists of specific binding sites for various 
biomolecules. They also have been shown to interact with a variety of other matrix components 
including laminin, fibronectin (31, 32), collagen (33, 34), and other bioactive molecules such as 






2.3 Pericellular Matrix 
Pericellular matrix (PCM) is a polymer matrix end-grafted on cells’ surface, and it’s 
sometimes referred to the cell coat or pericellular coat. The PCM is comprised of hyaluronan (HA) 
and bottlebrush proteoglycans (PGs) whose side chains consist primarily of the highly-negatively 
charged chondroitin sulfate. Strands of high molecular weight, linear HA are anchored to the cell 
surface by HA synthase and HA receptors (e.g. CD44, RHAMM).  The HA-binding bottlebrush 
PGs then assemble along the HA strands. These PCM components localize in micron-sized 
pockets under the cell, and remain distinctly spatially segregated from, but in coexistence with 
focal adhesions (36–39). The PCM has received minimal attention in the context of classic integrin 
regulated cell adhesion (39); yet many studies point to HA-rich PCM as playing a key role in 
mediating cell adhesion-dependent processes including embryogenesis, migration, proliferation, 
synaptogenesis, wound healing, and cancer (14). 
Both in vitro and in vivo, the PCM can also decorate the rest of the cell surface, embedding 
the cell in a halo of highly-hydrated supermolecular assemblies of HA and PGs, forming a 
hierarchical forest of bottlebrushes (Figure 2.1) (30). The swollen highly-negatively charged matrix 
repels objects away from the cell surface, demonstrating how the same components might exert 
forces on the substratum, resisting contact and adhesion to the surface by integrin-ECM 
interactions. Indeed, this repulsive effect is the basis of the so-called particle exclusion assay 
(PEA), the most common method used to determine whether a cell is enveloped by a sugary 
polymer coat (40). It is an indirect way to visualize the PCM where fixed red blood cells are added 
around the cells. The red blood cells are excluded from penetrating the area occupied by the 
matrix, and this exclusion region is the representation of the PCM’s physical extent (41–46). Like 
its ability to repel particles from reaching the cell surface, a plethora of direct and indirect data 






Figure 2.1: Pericellular matrix (PCM) is comprised of HA chains tethered to cell surface through 




or other cells. It appears that the PCM likely plays a dual role, regulating a delicate balance of 
weak attachment and strong repulsion, interfering with the ability/kinetics of integrin-ECM binding. 
  
2.4 Pericellular matrix functions 
The mechanism of PCM in the diverse functions are poorly defined but researches have 
shown evidences of the matrix impacts a wide range of diverse fundamental cell processes and 
disease states. The viscoelastic nature, makes the PCM play an important role in tissue 
homeostasis and biomechanical integrity, and a good mechanic protector inside cartilages to 
decrease the friction in the join (47). The PCM stands between the cell and its surrounding, so 
exogenous molecules pass through the matrix to gain access to the cells, hence it acts as a 
gatekeeper and is important in drug delivery (48) or localization and concentration of molecules, 










PCM and its components have been shown to have anti-adhesive properties and affect many 
adhesion-based physiological processes. For example, inside PCM, the interaction between HA 
and cell surface receptor increases the rate of cell proliferation (50) and migration (51, 52). The 
matrix is thus found to be important in wound healing (6, 53). The anti-adhesive property of PCM 
is also prominent in other area as well. The lecticans in the PCM regulate the synaptogenesis that 
removal of the PCM enhances the synaptic puncta (15). At the same time, HA macromolecules 
are essential for embryonic development, and lacking HA causes severe cardiac and vascular 
abnormalities which leads to the eventual death of the embryos (7, 54).  
Because of the high synthesis rate, PCM can also be used as marker for some diseases, e.g. 
osteoarthritis (55) and in various forms of cancer invasion. Many studies demonstrated PCM and 
its components, e.g. HA, lecticans and surface receptors, promote metastatic abilities of 
malignant cells (56–58). However, an special case on the naked mole rats showing the cancer 
resistant ability of this peculiar rodent came from the presence of HA, while downregulation of HA 
expression in the rats increase the cells’ susceptibility to cancer (59). It is also speculated that 





2.5 Particle Transport through PCM 
PCM interacts with particles around the cells and affect their accessibility to the cell 
surface. PCM has been known for its ability to exclude large particles. As mentioned before, 
researchers have been relying on this characteristic of the PCM to visualize and study this 
invisible layer on the cell with the technique Particle Exclusion Assay (Figure 1.1) (41–46). It was 
hypothesized that the complex structure of the PCM affects particles differently by size, e.g. 70 
nm dextran reaches about half a micron distance to the cell surface while the fixed erythrocytes, 
about 3 µm in size, are stopped several microns away from the surface (62). Even smaller 
molecules seem to be allowed through the matrix and gain access to the cells because the 
nutrition molecules can reach the cell and maintain cell viability. Those smaller molecules are not 
blocked by their sizes, but the HA matrix around cells still change how they diffuse through the 
matrix by electrostatic interactions (63). The electrostatic filtering prevents a portion of the 
particles reaching the surface, but for the ones reached the surface, research shows that PCM is 
helping the retention rate of the particles around the cells and enhance the intake (64). Our further 
studies of PCM’s impact on cell surface accessibility by particles/molecules are documented in 
Chapter 3 and 4. 
 
2.6 PCM in vivo vs in vitro 
Many of the experiments done on the PCM, including ours, are performed in vitro. Granted, 
the conditions of the PCM are different when it is around single cells cultured from a cell line than 
in the natural tissue environment. But there is still so much about the mechanism of the PCM we 
don’t know that the variable base is too large for in vivo studies to elucidate the detail mechanisms 






Figure 2.3: Focal Adhesion organization. Used by permission from MBInfo 




comprehensive in vivo study in the future. The mechanism and lessons learned in these in vitro 
studies will then be applied to the analysis of the future in vivo studies.   
 
2.7 Focal adhesions 
During cell adhesion, focal adhesions (FA) are formed to connect intracellular actin bundles 
to the extracellular matrix (Figure 2.3). The FA contains integrin and a wide variety of proteins 
that aggregate to the site (65). There are more than 100 different proteins at the FA, which 




carrier/sensor, which inform the cell about the condition of the surrounding ECM and affect the 
cell behaviors (67). FA is highly dynamic that grow or shrink due to the turnover of its component 
proteins in response to changing mechanical stresses  (68–71). At the interface, the 
transmembrane integrin binds to ligands on the substrate via short amino acid sequences, such 
as RGD that could be found in proteins such as fibronectin. It can attache to actin filaments inside 
the cell, and after traction force exerted by actomyosin contractions produces signal transduction 
events such as focal adhesion kinase (FAK) phosphorylation, so more adhesion proteins, such 
as talin, filamin, vinculin and tensin, are recruited to the FA and promote adhesion maturation. 
For the immobile cells, their FAs are stable. But during migration, the FAs undergo constant 
assembly and disassembly process. 
The dynamic assembly and disassembly of the FA plays a crucial role in cell migration. When 
the FA first form at the edge of the cell, integrin and some of the adapter proteins, e.g. talin, paxillin 
and tensin, are co-localized. Some of the nascent FA failed to mature and disassembled but some 
grew larger into a mature and stable FA by recruiting more protein, such as zyxin (72). After 
mature FA formed at the leading edge of a migrating cell, it become stable and the actin retrograde 
flow, which is the polymerization of the actin filaments at the leading edge and flow back towards 
the cell body, drive the cell forward (73). The matured FA stay under the cell until it reaches the 
trailing end of the cell edge. The FA then go through an unknown process to start disassemble 
and recycles the integrin and other proteins (74). Huttenlocher et al suggests it is regulated by 
calcium-dependent protease calpain, whose inhibition has been shown to inhibition of FA-ECM 
separation (75). In this work, we are providing another possibility.  
Although HA expression at the cell interface and its presence in PCM are correlated with many 
processes that involve change in adhesion state (migration, proliferation, synaptogenesis, contact 
inhibition and the numerous activities that involve cell migration and proliferation including wound 




adhesion machinery and hyaluronan function together and whether their apparently dual roles as 
an adhesive and repulsive mechanism are orchestrated in a meaningful way that impacts cell 
mechanics. Below we review much of what has been reported to date. The rest of this thesis, 
especially chapters 5, 6, and 7 are focused on providing more data and insight regarding the 
relationship between integrin-mediated adhesion and hyaluronan expression. 
 
2.8 Focal Adhesion and Hyaluronan 
Many studies have been done to relate HA to cell adhesion-related processes. 
Accumulation of HA has been shown to inhibit cell contact (76–78), increase cell migration and 
proliferation rate (3, 79), promotes malignant cancer phenotypes (80–82) and is important during 
embryogenesis (8). HA is added for better wound healing in surgery for its migration and 
proliferation enhancement ability (6, 83). Some studies also shown that HA plays an important 
role in early adhesion events (65, 84). But the mechanism of HA’s regulation on focal adhesion is 
still unknown. Some researchers have suggested that HA and HA receptors create a rapid and 
transient protein tyrosine kinase signaling event to change adhesion (85). HA also has been 
shown to activate protein kinase signaling to modify focal adhesion also through its receptor (86). 
Only a handful of studies investigates the direct impact of the HA on the focal adhesion. Twarock 
et al showed degradation or displacing HA on cell increases the cleavage of FA and destabilize it 
(87). And a recent 2014 study demonstrated that HA matrix, or bulky glycocalyx, exerts force on 
the adhesion receptors, aggregate the integrin cluster, and regulate the adhesion assembly (88). 
We are aiming to take another route than those. Instead of the stability of FA, we want to study 






2.9 FA Area and Traction Force 
In Chapter 5 & 6, we discuss how the PCM affects the adhesion strength of cells, which 
is how much force is needed to detach the cells from substratum. In order to test our hypothesis 
of PCM exerting repulsive force between cell and substrate and thus decreasing the adhesion 
strength, we use enzyme to change the PCM condition and monitor the change in cell adhesion 
strength. However, to find the effect of PCM change on adhesion, our assumption is that the 
strength of the integrin-ligand binding strength remain after enzyme treatment.  
FA composition changes in different stages of maturation. Their shape and size altered 
as well; they change from a circular, submicron dot to an elongated plaque with a 0.5-1 µm width 
and lengths up to several micrometers through maturation (89). FA size change might come from 
internal cytoskeleton contraction or external force (90). And many studies found direct correlation 
between FA size and local traction force (67, 91, 92). However, there are studies showing a 
complex relationship between the FA size and the force it exerts. There’s one study shows an 
inverse correlation between the size and traction stress at the front of the migrating cell but finds 
no such relationship at the rear end. It has been shown that extremely large super mature FAs 
exerts a high stress (91), while the small FAs ~1 µm exhibit a widely variable stress (92). Striker, 
et al in a 2011 publication demonstrates elegantly that the size dependency of the traction force 
only occurs at the initial stages of myosin-mediated adhesion maturation and growth, and for 
mature FA, no correlation was observed (93). Hence, when monitoring the FA strength, only 
measuring the FA size is not enough, so other measurements are made to compliment it to test 









Organization and Microstructure of the Pericellular Matrix 
 
3.1 Overview 
The functions of the PCM are not well defined but studies show that the matrix influences 
a wide range of fundamental cell processes and disease states including cell adhesion, 
proliferation (50), motility/ migration (51, 52), synaptogenesis (15), embryonic development (7, 
54), mechanotransduction (60, 61), protection from viral infections (94), morphogenesis, 
mechanical protection (47), drug delivery (48), wound healing (6, 53), sequestration of growth 
factor, osteoarthritis (55) and various forms of cancer invasion (57, 58, 95).  
Improved characterization methods are needed to clarify the mechanisms by which the 
PCM contributes to these cellular functions. Until very recently, the tools to characterize 
pericellular matrix were limited and crude. As a result, the fact that an extended polymer coat is 
present on many cell surfaces in vitro and in vivo has been neglected, and possibly 
underappreciated. Part of the difficulty in studying the PCM is that it is not visible in traditional 
bright field microscopy. Due to its hydration, the PCM has similar index of refraction as the 
surrounding fluid, and it appears as if nothing is there. For the small number of researchers 
interested in studying PCM, the most convenient and common method used to visualize is the 
crude particle exclusion assay (PEA) (40), introduced in Chapter 2. Others have tried to 
fluorescently label the hyaluronan or the lecticans but accurate characterization was thwarted by 
the destruction of the PCM structure by fixation procedures. Only recently have fluorescent labels 
for HA become available that could be used on living cells (96). This has transformed the ability 
to study PCM during the many physiological events described above. To study the biophysical 
and physiochemical roles of the PCM, our lab has made it a mission to expand the tools to 




established to go beyond the traditional schematic of PCM organization (Figure 2.1) and the 
surprising but not very informative images made with particle exclusion assays.  
This chapter summarizes our development of a new technique and the information it 
provides during PCM characterization. We call the approach the quantitative particle exclusion 
assay (qPEA) (97, 98), because the basic idea is to examine how the PCM interacts with 
nanoparticles of different sizes. The method yields information regarding the microstructure of the 
PCM as well as the accessibility of the cell surface to nano-objects when the PCM is a barrier. 
Insight into the openings and porosity of the PCM is novel information; further, insight into how 
nanoparticles, exosomes and even molecules diffuse through the PCM is critical both for 
envisioning how PCM regulates cell-cell interaction in the body as well as for in vitro studies of 
classic topics ranging as far as drug delivery, phagocytosis to the new exciting area of exosome 
biology. 
 
3.2 Material and Methods 
3.2.1 Cell culture and sample preparation 
Rat chondrocyte joint cells (RCJ-P, fetal calvaria, batch 15.01.98; Prochon Biotech, Rehovot, 
Israel) are cultured under 37°C, 5% CO2 with α-MEM, 15% FBS, 2% L-glutamine (Mediatech, 
Manassas, VA). Human prostate cancer cells (PC3, ATCC: CRL-1435) are cultured under 37°C, 
5% CO2 with ATCC-formulated F-12K Medium (ATCC: 30-2004) with 10% FBS. The cells are 
plated for 18-20 hours at low density on 78.5 mm2 (5x104 cells for RCJ-P and 30k for PC3), and 
measured during passages 15-40. Mesenchymal stem cells (MSC, human bone marrow-derived, 
Texas A&M, College Station, TX) are cultured at 37°C, 5% CO2 with α-MEM, 16.5% FBS, 2 mM 
L-glutamine, 100 U/mL penicillin and 100 μg/mL streptomycin. Human breast cancer cells (MDA-
MB-231, ATCC: HTB-26) are cultured under 37°C, 5% CO2 in DMEM with 4.5 g/L glucose 




cultured under 37°C, 5% CO2 in DMEM with 2.2 g/L sodium bicarbonate (ATCC 30-2002), 10% 
FBS, and 0.1% bovine insulin (Sigma: I0516). Chinese hamster overy cells (CHO-K1, ATCC: 
CCL-61) are cultured under 37°C, 5% CO2 with F-12K (Cellgro: 10-025CV) and 10% FBS. 
Fluorescent imaging is held at 37°C and 5% CO2 with a stage-top incubator (N. E-MSI 07-
3156, Okolab, Ottaviano, NA, Italy). During RICM, a different stage-top microscope incubator 
(LiveCellTM, Pathology Devices, Inc., Westminster MD) maintained the cells at 37°C, 5% CO2, 
80% humidity in order to keep the cells viable for long-term experiments. 
The sample holder used for experimentation is made of nonstick Teflon and has a small 
well in the bottom that is covered with a 25x25 mm #1.5 glass coverslip (VWR: 48366-249). RCJ-
P was seeded on cleaned glass coverslip directly while PC3’s coverslip was coated with collagen 
and Hs578T’s coverslip was coated with fibronectin. Method of coating coverslip is described 
below. To minimize volumes used, the typical well can hold a volume of 200 μl. After assembly 
the sample holders are exposed to a UV light on each side in order to insure sterility. 
 
3.2.2 Particle exclusion assay (PEA) 
Traditional PEA: fixed sheep erythrocytes (R3378; Sigma Aldrich, St. Louis, MO), are suspended 
in PBS and then added to the sample with a final concentration of 1 mg/mL to achieve mono-layer 
after 10 mins. Thickness of the PCM is measured to be the perpendicular distance from the cell 
plasma membrane (at the flattest location on the cell, usually the middle) to the nearest 
erythrocyte. 
Quantitative PEA (qPEA): fluorescent polystyrene spheres (FluoSpheres; Invitrogen) of 
different sizes are passivated before use in qPEA. For passivation, larger particles (>200 nm) are 
reversibly swollen with toluene to enable physical entanglement of Pluronic F127 as previously 




(Fluka, St. Louis, MO) (100). For qPEA, 22 μL of the microspheres (5% solid) are added to 178 
μL media and allowed to settle for 10 min. The properties of passivated nanoparticles are 
assumed to be the same with different passivation methods but there might be differences. To 
facilitate image analysis, the cell surface is fluorescently labeled with wheat germ agglutinin 
(WGA-Alexa Fluor 633 conjugate; Sigma), which is added to the sample (125 μg/mL) 5 mins 
before measurements are obtained. Location of the membrane is determined to be the highest 
fluorescent intensity. The samples are imaged with a confocal microscope (FV1000; Olympus, 
Tokyo, Japan). Microsphere distribution is measured by taking the fluorescence intensity 
perpendicular to the cell surface at 3 μm above the glass surface and averaged over 2 μm. The 
effective thickness, deff, is identified to be the distance between cell surface and the plateau in the 
average bead intensity.  
The presence of the microspheres inside cell culture media was limited to the experimental 
time of two hours in order to minimize the effect on cell health and behavior.  
 
3.2.3 Hyaluronan labeling: GFPn production and use 
Rauch et al. (96) designed a cDNA strand that encodes for a protein where a green fluorescent 
protein (GFP) molecule is connected to a neurocan link protein (96, 101). Neurocan is a 
proteoglycan similar to the aggrecan in our system, which has a similar structure where the first 
domain of the backbone is the link that binds specifically to hyaluronan. The resulting protein 
(called here GFPn) specifically labels hyaluronan with GFP, resulting in the ability to fluorescently 
image the cell coat. This plasmid is transected into HEK cells in order to produce the GFPn 
molecule. HEK cells were gifted by U. Rauch (Uppsala University, Uppsala, Sweden), and are 
cultured with a 1:1 mixed D-MEM/F12 (Mediatech), 10% FBS, 1% L-glutamine (Mediatech) and 




puromycin can be toxic to recently thawed cells. After transfection, the HEK cells translate the 
cDNA into the GFPn molecule via the typical protein production cell machinery, and the GFPn is 
then released into the cell media. For GFPn production, the transfected HEK cells are plated into 
five 175 cm2 flasks and allowed to reach confluency (~ 4 days). The media is then removed and 
replaced with FBS free media. Every 2 days the media is collected and replaced again with FBS 
free media. The collected media is a solution of media, dead cells, and molecules excreted by the 
cells, including the desired GFPn. The collected media is centrifuged at 2000 rpm for 20 minutes 
in order to separate the dead cells and large debris from the media. The supernatant is then 
collected and treated with protease inhibitor (Thermo Scientific). This procedure is repeated for 
2-3 collections, as after this point the cells no longer produce measurable GFPn. If more GFPn is 
required, another set of 5 flasks must be plated and the process restarted.  
After the desired quantity of collected media is taken, it is then centrifuge filtered (Millipore 
Amicon Ultra: 15-30 k), which collects any molecules larger than 15-30 kDA and lets those smaller 
pass through the filter. After initial filtration, typically 20% of the total initial volume remains. The 
remaining media (which contained the GFPn molecule) is then filtered again, this time with a his-
tagged protein purification column (Pierce, HisPur Cobalt). In short, these columns have a resin 
that has a high affinity for his-tagged proteins, which is included in the design of the GFPn. The 
remaining media is filtered through this column 400 μl at a time. Any non his-tagged proteins and 
media easily pass through the resin and column, leaving only the GFPn remaining. The column 
is then eluted with a buffer (as directed by the product sheet), which released the GFPn from the 
resin, and is collected with a 200 μl volume of elution buffer. Releasing the GFPn with the elution 
buffer is performed three times as the first pass is not 100% efficient, resulting in three collections. 
The fluorescence signal of the GFPn solution is then checked with a UV Vis machine to verify 
collection and to quantify the amount of protein. 
In order for cell treatment, the GFPn solution is then run through a buffer exchange column 




for releasing the GFPn from the resin column, is not the correct pH or salt density for cell 
treatment. The buffer exchange protocol requires the desired buffer to be run through a column 
multiple times, followed by a run with the GFPn media. This results in a GFPn solution in PBS 
and is ready for cell experimentation.  
GFPn solution is added directly to the samples to achieve the desired concentration. 
Unless otherwise noted, 10 μl of the GFPn is added to 100 μl of media in the cell sample. The 
GFPn solution is then allowed to incubate with the cells for 15 minutes in order to let the molecules 
fully incorporate themselves within the cell coat. HA patches are imaged at the glass slide level. 
The location of the glass is judged by the excess GFPn on the glass. Controls show that GFPn 
does not attach to glass without cells present and longer the cells on the glass, more GFPn 
concentration is present on glass. 
 
3.2.4 Optical force probe assays (OFPA) 
Optical force probe assays are performed by using a static calibrated optical trap (OT) and a 
programmable stage (ProScan H117; Prior Scientific, Rockland, MA). In a typical experiment, an 
OT holding a 3 μm passivated microsphere is positioned 20 μm outside of the PCM, where it can 
be translated toward and away (orthogonally) to the cell surface at 8 μm/s. The OT is paused for 
5 seconds at the cell surface (always at a distance of 3 μm) and outside of the matrix. The forces 
on the probe are extracted by using a standard subpixel particle-tracking algorithm (102) to find 





Figure 3.1: Traditional PEA on (a) RCJ-P rat’s chondrocyte, (b) human mesenchymal stem cell. 





3.3.1 Traditional Particle Exclusion Assay (PEA) characterization of cell lines  
Characterization of the PCM using the traditional erythrocyte PEA was performed on 
several cell types (Figures 1.1 and 3.1), both to verify the presence of the PCM as well as for 
comparison with the qPEA results. More generally, we typically use PEA or fluorescent labeling 
of HA as a quick check for the presence of PCM before moving forward with more sophisticated 
assays. In these assays, the thickness of the PCM was measured to be the perpendicular distance 
from the plasma membrane to the edge of the erythrocytes. The measurements were performed 
in the middle of the side of the cell, where it is locally flat, to be consistent with the other techniques 
done in our lab. In other laboratories, the convention is sometimes to report the entire area of the 
PCM – another useful quantity. However, since we tend to think in terms of a polymer brush-like 










average thickness of the cell coat (e.g. brush) is more useful. We measure at on typical location 
because the relative thickness of the coat varies with position on the cell surface. 
Figure 3.1a shows a typical PEA on RCJ-P cells. The PCM thickness is measured at the 
center on the side of the cell as indicated as the yellow line in Figure 3.1a. The average PCM 
thickness for RCJ-P is 7.30 ± 0.92 μm (N=114). The PCM thickness was also measured using 
fluorescent labeling of HA on the live cells (GFPn) and we found that the average thickness is ~6 
μm (see Figure 3.2). Dr. Louis McLane, a former student in the Curtis lab also performed optical 
force probe assay (OFPA) by using optical tweezers (OT) to probe the PCM and found that when 
the probe was moving into the PCM (a dynamic measurement), a force on the probe was felt on 
average at distances 11.5 ± 1.10 μm from cell surface; static equilibrium OT measurements 
detected force (on bead held in static trap) at a distance of ~8.0 ± 0.6 μm and closer (summarized 
in table 3.1).  
Despite measurements on the same cell line, different methods yielded different PCM 
thicknesses.  The GFPn measurement of the cell coat thickness is similar to the visualized by 
PEA. But comparing to the GFPn images before adding RBC for PEA (Figure 3.2a) and after the 
RBC addition (Figure 3.2c), the GFPn intensity is higher at the edge of the PCM, showing HA is 





Figure 3.2: GFPn and PEA show the extent of PCM around the same RCJ-P cell (a) GFPn before 
adding RBC for PEA (b) superimpose image of GFPn and bright field image after adding RBC (c) 




be the reason behind the detected thickness between the optical force prove and PEA. However, 
the GFPn labeling can also only detect the PCM up to around 6 μm due to the low concentration 
of HA, therefore low GFP intensity, beyond that. 
Looking more closely at the images, some part of the PCM seem like there is a thin gap 
between the end of the GFPn signal and the location of the nearest RBC (on the left side of the 
cell in Figure 3.2b). It could be because the disk-like RBC are packed in a specific way and get 
stuck. Also it was noticed that some RBC might penetrate into the PCM more than the others 
depending on the orientation of the disk-like RBC (on the right side of the cell in Figure 3.2b). 
Again, the non-uniform shape of the RBC is decreasing the quantitative quality of the PCM 
thickness measurement. 
On the other hand, the PCM thickness is not the same on different cell lines. To complete 
the record in this thesis, the PCM thickness for the following cell types we have in our lab are 
reported. On the human prostate cancer cells, PC3, the average thickness is 3.89 ± 0.36 μm 
(N=127). The breast cancer cells, MDA-MB-231, have very small PCM around them. So the PCM 




does not have a well-defined shape, and the PCM around those cells is seldom uniform around 
the cells, despite the fact that those cells produce copious amounts of HA. The average thickness 
reported here is taken from the thickest part of the PCM on a single cell. Many of them have no 
PCM thickness and that also have been factored into the average, which is 5.79 ± 0.74 μm (N=41). 
Human mesenchymal stem cells (MSC), have an average PCM thickness of about 6.60 ± 1.60 
μm (N=72).  
As mentioned above, optical force probe assay (OFPA) with optical trap technique was 
utilized to study the PCM. Here is a quick summary of his work (97). Optical trap pushes a 3 μm 
bead into the PCM. The outcome of these measurements inspired the work reported here, so the 
technique and results are briefly summarized here. Force on the bead can be calculated by the 
degree of the position deviation from center of the trap. The measurements show that the PCM 
is a robust yet malleable structure. The PCM tolerates repeated probing with the bead without 
any measurable changes. There are two different types of measurements made by the OFPA. 
The dynamic measurement is taken during the movement of bead and can detect the PCM 
presence further away from cell than the other methods (Table 3.1). The equilibrium measurement 
is the force measurement done after the bead stop and equilibrate at various distance to cell 
surface. The higher equilibrium force measured closer to the cell surface fueled the hypothesis of 
a varying polymer distribution, which is complementary to our observation in the next section. 
As discussed in the introduction and as is evident here: traditional PEAs are an excellent 
tool to assess the presence of thick PCMs and for characterizing the extent in thickness and area 
around the cells. It is less ideal for cells with thinner PCM (or as we find cell coats comprised of 
long HA polymers but little bottlebrush proteoglycan) because the images are difficult to analyze 
and the asymmetry of the red blood cells and the error arising from their large size adds 
imprecision to the measurement. They may distort the PCM via pressure, as suggested by the 





Figure 3.3 RCJ-P visualized with (a) 100 nm size particles in red and (b) 2 μm size particles in 




Further, they provide no information to further our knowledge regarding the interior of the PCM 
given that the OFPA shows the PCM has an interesting varying mesh size structure (97). 
Therefore, we developed an improved technique to probe the internal structure of the cell coat 
and present it in the next section. 
 
3.3.2 Quantitative Particle Exclusion Assay 
To better investigate the structure of the PCM, we developed a complementary assay that 
we refer to as the qPEA. In this approach, we use passivated microspheres of well-defined sizes 
to probe the accessibility of the PCM for objects of different sizes (Figure 3.3). These assays 
show that particles become non-uniformly distributed throughout the matrix in a size-dependent 
fashion. To quantify the variation and size dependence, we measured the intensity profiles of 
fluorescent microspheres as a function of distance to the cell. Figure 3.4a shows typical intensity 
profiles associated with different particle sizes. A typical intensity profile for particle sizes < 500 
nm consists of a nonzero intensity at the cell surface followed by a gradient of increasing intensity 





Figure 3.4: (a) Quantitative particle exclusion assay (qPEA) using monodisperse passivated 
beads ranging from 40 nm to 500 nm in diameter. (b) The effective thickness, deff, is measured to 
be distance from cell membrane to the position where bead intensity reach plateau (profile of 100 
nm beads). This profile of the 100nm bead distribution is smoother than that in (a) because it is 




zone. The oscillations in the qPEA bead profiles are due to the diffusion of the finite size particles 
during confocal imaging. However, as the particles diffuse about their locations, these peaks 
become spread out, as the confocal imaging is not instantaneous. These oscillations are 
smoothed out by averaging over series of images. 30 successive images are averaged to have a 
smoother profile (Figure 3.4b bead profile). The fluorescent bead profiles show that the bead’s 
concentration is the lowest at the cell membrane and roughly plateaus at a distance, we term it 
effective thickness, that depends on the particle size. The effective thickness, or deff, is measured 
by the distance between the cell membrane to the plateau of the bead intensity, as showed in 
Figure3.4b. We extracted the average effective thickness for particle diameters of 40 nm, 100 nm, 
200 nm, 300 nm, 400 nm, 500 nm, 2000 nm, and 3000 nm, as shown in Table 3.2.  
Analysis of the particle distribution as a function of bead diameter show that the PCM acts 
as a sieve for passivated particles of different sizes. Figure 3.5b shows how the average effective 
thickness of the coat increases with increasing particle diameter, with results given for bead sizes 















Figure 3.5 (a) Schematic of the qPEA showing measurements of deff for different bead sizes. 
Experimentally only one bead size is added at a time. (b) The effective thickness associated with 
bead size increases until it plateaus at ~ 8.5 μm where 500 nm size beads and larger are excluded 




distances into the cell coat is consistent with the optical force measurements, suggesting that the 
ability of particles to penetrate the pericellular matrix decreases as the particle size increases, 
confirming that the mesh size is indeed spatially varying. Interestingly, particle sizes of 500 nm 
and greater have the same average effective thickness, deff,500= 8.5 ± 0.8 μm, suggesting that this 
is the edge of an inner domain within the PCM. This measurement of the edge of the cell coat is 
also consistent with the equilibrium thickness measured by the optical force studies, which is 8.0 
± 0.6 μm. However, it is slightly larger than the mean thickness of the red blood cell PEAs, 7.30 
± 0.92 μm, and the fluorescent HA assay, 6.00 ± 1.00 μm, as discussed below. 
 
3.4 Discussion 
The different methods of probing the PCM are shown. While they each reveal new and 
interesting information about the structure of the cell coat, comparison between the two assays 
strengthens the results and our interpretation of what these results reveal about the PCM. The 
optical tweezer force probe assay (OFPA) results were used to extract a pore size profile 
throughout the coat. Correlation length can also be thought of a ‘mesh size’, or an average 
opening within the polymer mesh. This non-constant correlation length profile is interpreted to 
mean that the average opening in the cell coat is not constant, and that the size of the openings 
within the coat increases at distances further away from the cell membrane. We take this concept, 
and use it to directly compare the OFPA results to the results from the quantitative particle 
exclusion assays (97). The qPEAs revealed that the cell coat acts like a sieve, separating particles 
by their size. Smaller beads were able to penetrate further, as their smaller sizes apparently permit 
them to fit inside the tighter spaces within the cell coat. This section directly compares these 
results in order to develop a cohesive understanding of the PCM structure. 
Conceptually, the results from the OFPA and qPEA studies are highly compatible, as a 
varying correlation length can be directly interpreted that that the coat acts like a sieve for the cell. 




larger particles will be stuck outside the cell while the smaller particles are allowed to penetrate 
through the cell coat. This would allow smaller molecules such as growth factors to reach the cell 
surface, while larger possibly undesirable matter is kept away from the cell surface. The qPEAs 
directly demonstrate that the cell coat behaves in this manner. The position to where a particle 
can easily penetrate, defined as the effective thickness (deff), correlates directly with bead size, 
where larger particles are held further away from the cell membrane. 
Further, the qPEA results can be semi-quantitatively compared to the correlation length 
profile predicted by the OT work. Recall that the effective thickness, deff, for a particle is the 
distance to the cell surface at which the concentration of the particle distribution reaches a 
plateau. At this location the mesh size of the coat is considered to be the same as the size of the 
particle. Thus particles can easily penetrate any regions of the coat where the mesh size is larger 
than their diameter. However when the particles reach a mesh size that is smaller than their 
diameter they are stopped by the PCM, as they can no longer easily diffuse past this point. Some 
of the particles do pass this point, but this is likely due to the fact that the coat is not a stiffly 
crosslinked network, as fluctuations in mesh size and particle position result in some of the 
particles passing this point. The qPEA profile can then be thought of as a probability distribution 
for the positions of a particle within the cell coat. 
Thus for a quasi-quantitative comparison, we conjecture that the bead size corresponds 
roughly to the correlation length in the PCM at the effective thickness where that bead size shows 
constant concentration. In other words, the deff from the qPEA results corresponds to the distance 
to the cell, and the bead size corresponds directly to the correlation length at this position. We 
note that 40 nm bead data are excluded from this comparison because the plateau is at deff,40 = 
1.4 ± 0.3 μm, a distance where microvilli complicate the PCM structure on RCJ-P cells (103). With 
these assumptions, the qPEA data can be recast as correlation length versus position in the 
pericellular coat. Overlaying the optical force data with the ad hoc qPEA curve provides a visible 





Figure 3.6: Comparison between the correlation length profile calculated from the optical force 




mesh size for increasing distances from the cell. Additionally, for beads larger than 200 nm the 
two agree within error. Although they do not fully agree quantitatively, the two assays are 
conceptually consistent as they both show an increasing mesh size at distances further from the 
cell membrane. 
The data extracted from the optical force probe and qPEA assays together provide strong 
evidence that the pericellular matrix has a spatially varying mesh size. The penetration of 40 nm 
particles to the surface and their uniform distribution at deff,40=1.4 μm suggests the mesh size 
ranges from a sub-100 nm length scale near the surface to ~500 nm at a distance of approximately 
eight microns from the cell surface. The comparison of the qPEA results to the correlation length 
profile refines our grasp of the true values for the mesh size of the cell coat, as the calculation of 
the correlation length is only semi-quantitative given the fact that there is an unknown scaling 
factor in its result. 
 We tried qPEA measurement on the same cell to have a better size-dependent deff 
comparison, but when performing qPEA with 100 nm and 1 μm beads, the effective thickness of 
the larger size bead fluctuated too much. The average thickness when measured with 1 μm beads 




measured by 1 μm ranged from 3 μm to 12 μm, which was unusual in qPEA. There might be 
dynamic interactions between different sizes beads. To stay on track of our mission for 
characterizing the PCM structure, we suspended the effort for multi-size qPEA on the same cell. 
The large size qPEA measure the outer edge of the PCM is at 8.5 μm where the RBC 
showed just a ~7 μm thick coat. As discussed before, RBC tend to compress the PCM. Also, the 
non-uniform size and shape of the RBC make it hard to be accurate in the thickness 
measurement. qPEA improves on that. 
 Comparing the qPEA technique to GFPn labeling, the two methods are quite different. 
GFPn shows the direct distribution of the PCM structure, while qPEA maps out the PCM 
microstructure by showing the empty space inside the matrix. And that in turn gives us an insight 
into how molecules can access to the cell surface. These two techniques are complimentary to 
each other. The information of the HA distribution combines with the open space distribution 
inside the matrix obtained by qPEA, the presence and distribution of other molecules, such as the 
large bottlebrush CSPG, could be inferred. More work on the two techniques done on the single 
cell is needed to have further insight. 
We briefly acknowledge a few disadvantages of the qPEA assay. Most importantly, 
although the effect is small, the beads inside the PCM occupy the available space for the polymers 
and therefore change the dynamics and the configuration of the polymers. More work is needed 
to determine how critical this impact is. For the smaller beads (40 nm), after they reach the cell 
surface, they sometimes aggregate on the membrane despite the passivation or are endocytosed 
by the cell. This might disrupt the cell health or block hyaluronan synthesis or binding (to CD44) 
and interfere with long term experiments.  
A technical issue worth mentioning is that during qPEA, because of the high diffusivity of 
the microspheres and their small size, bright field images cannot be taken to identify their 
positions. Indeed, even with a confocal microscope, at the concentrations used here and the 




particle micro-rheology of 300 nm particles in the PCM in the past (103)). This however, worked 
to our advantage because we were primarily interested in the probability of a particle being a 
certain distance from the cell surface. Therefore, blurred snapshots of particles in transit were 
acceptable. Indeed, we even averaged over many images (N=30) in order to achieve smoother 
profiles.  
 
 3.5 Conclusion and Outlook 
The PCM is a neglected but important construct of single cells. A growing body of evidence 
suggests that the mechanical and structural properties of this cell-associated matrix influence 
numerous physiological processes. Meanwhile, researchers working in bioengineering and drug 
delivery are increasingly concerned with the influence of the PCM, and possible opportunities to 
manipulate it to realize their applications. In similarity to other passive and active micro-rheology 
approaches used to interrogate the viscoelastic properties of cells, in this work we introduce novel 
physical assay to nondestructively interrogate the organization of the PCM. We developed a novel 
qPEA to look at the size-dependent diffusion of (passivated) particles into the PCM. To the best 
of our knowledge, our assays provide the first quantitative evidence that the pore size of the PCM 
varies with distance to the cell surface. The spatial and chemical variations in the cell coat will 
greatly influence the transport of objects and molecules to and from the cell surface. In these 
studies, we minimized the role of chemical interactions to focus on steric exclusion by using 
PEGylated particles. The outcome demonstrates that even without the electrostatic repulsion or 
chemical interactions that are expected to occur in the highly negatively charged matrix due to 
bottlebrush CSPGs, access to the cell surface is affected by the cell coat microstructure. This has 
direct implications for cell defense against viral and bacterial infections, and drug delivery 
applications. 
In conclusion, this work introduces the novel (to our knowledge) biophysical strategy to 




PCM on RCJ-P cells. Experiments showed that the PCM has a varying pore size and can sieve 
incoming nanoparticles by their sizes. These insights and others that will be gained in future work 
based on these tools should provide researchers with useful clues to unravel the mechanisms by 







Cell surface access is modulated by tethered bottlebrush proteoglycans 
 
4.1 Overview 
The cell interface is critical in mediating the integration of cells into tissue via extracellular 
matrix (ECM) and cell-cell contacts. Cells that maintain hyaluronan-rich sugar coats on their 
surfaces may have enhanced capabilities to manipulate their very local environment and hence 
direct their interactions with cells and the ECM (13, 14) (Figure 4.1).  This is particularly relevant 
in dynamic tissue environments, where sugar cell coats are involved in the regulation of a wide 
range of processes that involve cell rearrangements including cell migration (41, 42, 76), division 
(104), synaptogenesis (105), morphogenesis (3, 106), cancer progression and metastasis (107–
109). The aim of this study is to investigate the physical role that the hyaluronan sugar coat plays 
in mediating cell surface access.  
The potential significance and impact of the hyaluronan-rich cell coat, also called the 
pericellular matrix (PCM), is immediately evident when glancing at a cell endowed with a cell coat 
(Figure 4.1). On many cell types, the PCM extends more than 5 microns from the cell surface and 
on some cell types it extends up to 20 microns (14). Indeed, PCM visualization is traditionally 
achieved by utilizing one of the important properties of this surface-anchored polymer matrix, i.e. 
its ability to repel objects from the cell surface (Figure 4.1b). There are three essential components 
in the cell coat (14): the linear carbohydrate hyaluronan (HA), HA-binding proteins at the cell 
surface, and HA-binding bottlebrush-shaped proteoglycans, also known as hyalectins (110).  In 
the PCM, HA polymers are anchored to the cell surface by proteins (e.g. CD44, RHAMM) or they 
remain tethered to the enzyme HA synthase, which directly extrudes HA from the plasma 
membrane.  With lengths ranging from ~2-25 μm (13), cell-surface tethered HA becomes 




which includes aggrecan, versican, neurocan and brevican, consists of core proteins that are 
extremely similar within the N- and C-terminal globular domains and have central domains of 
variable length with multiple sites for the addition of chondroitin sulfate or dermatan sulfate chains 
and O-linked oligosaccharides. The hyalectins are present in the ECM and PCM of many tissues, 
with aggrecan featured in cartilage, brevican and neurocan abundant in the central nervous 
system, and versican expressed in most soft tissues of the body (111).  All hyalectins contain a 
common HA-binding domain (G1) that allows them to aggregate densely along HA, nearly 
permanently when reinforced by an additional protein called link protein (30). The key physical 
characteristics of the bottlebrush proteoglycans stem from a second domain (G2) that contains a 
dense region of highly-sulfated glycosaminoglycans. The third and last domain (G3) is smaller 
and consists of specific binding sites for various biomolecules.  Cell coats can exist without 
bottlebrushes but unless the HA is grafted so densely that a polymer brush forms (as on some 
bacteria (112)), the PCM is relatively thin even when comprised of large HA molecules. It is the 
aggregation of bottlebrush proteoglycans in the PCM that generates its voluminous expansion on 
most mammalian cells (30, 113), and which dominates the physical and chemical functions of the 
PCM. 
Little work has focused on spatial characterization of bottlebrush molecules in the cell coat 
nor how their distribution and physical properties impact accessibility of the cell surface. Most 
biophysical studies have focused on structural and biomechanical properties (97, 103, 114, 115). 
While chondroitin sulfate proteoglycans are known to have important biochemical roles (35, 111), 
their unusually large size, their ability to be densely aggregated on HA, and their high negative 
charge should also strongly influence the physical interaction of proteoglycan-rich PCM (and 
ECM) with molecules (35), cells (15) and particles (43) including drug delivery vehicles, 
exosomes, and supermolecular aggregates. The work presented here examines the spatial 





Figure 4.1: (a) Cross-sectional confocal image of pericellular matrix swollen with exogenous 
aggrecan on RCJ-P cell (cACAN=333 μg/mL, yellow=aggrecan, white=plasma membrane). The 
PCM extends in a three dimensional halo around the cell, with aggrecan intensity visible at 
distances more than 20 μm from cell surface. (b) Schematic of the PCM. Hyaluronan polymers 
(green) bind to the plasma membrane via HA-binding membrane proteins (blue). Bottlebrush 
proteoglycans (black) bind along the chain and stretch the HA into an extended configuration. (c) 
Erythrocyte particle exclusion assay shows the extent of the cell surface-grafted PCM on 
aggrecan-saturated mesenchymal stem cell (333 μg/mL for 2 hrs). (d) Erythrocyte particle 




40 nm and larger are altered in their access to the cell surface; we report that free bottlebrushes 
diffuse through the PCM, and demonstrate that positively charged molecules become 
sequestered in the PCM on chondroitin sulfate side chains of bottlebrush proteoglycans. These 
systematic investigations have direct implications for PCM function and are a first step towards 






4.2 Materials and Methods 
All data are reported with 2 standard error in text and in plots. 
4.2.1 Cell culture and sample preparation 
Rat chondrocyte joint (RCJ-P) cells (fetal calvaria, batch 15.01.98; Prochon Biotech, Rehovot, 
Israel) were cultured under 37°C, 5% CO2 with α-MEM, 15% FBS, 2% L-glutamine. Mesenchymal 
stem cells (MSC) (human bone marrow-derived, Texas A&M, College Station, TX) were cultured 
at 37°C, 5% CO2 with α-MEM, 16.5% FBS, 2mM L-glutamine, 100 U/mL penicillin and 100 μg/mL 
streptomycin. Cells were seeded on glass coverslips in Teflon sample holders for ~20 hours to 
achieve 50% confluency of the 0.8 cm2 surface with 2 mL of media. During the imaging, samples 
were held at 37°C, 5% CO2 and 80% humidity with a stage-top incubator (N.E.-MSI 07-3156; 
Okolab, Ottaviano, Italy).  
 
4.2.2 Particle exclusion assay (PEA) 
Traditional PEA: fixed sheep erythrocytes (R3378; Sigma Aldrich, St. Louis, MO), were 
suspended in PBS and then added to the sample with a final concentration of 1 mg/mL to achieve 
mono-layer after 10 mins. Thickness of the PCM was measured to be the perpendicular distance 
from the cell plasma membrane (at the flattest location on the cell, usually the middle) to the 
nearest erythrocyte. 
Quantitative PEA (qPEA): fluorescent polystyrene spheres (FluoSpheres; Invitrogen) of 
different sizes were passivated before use in qPEA. Larger particles (>200 nm) were reversibly 
swollen with toluene to enable physical entanglement of Pluronic F127 as previously described 
(99). Smaller particles were covalently modified with methoxypolyergylene glycol amine (Fluka, 




media and allowed to settle for 10 min. To facilitate image analysis, the cell surface was 
fluorescently labeled with wheat germ agglutinin (WGA-Alexa Fluor 633 conjugate; Sigma), which 
was added to the sample (125 μg/mL) 5 mins before measurements were obtained. The samples 
were imaged with a confocal microscope (FV1000; Olympus, Tokyo, Japan). Microsphere 
distribution was measured by taking the fluorescence intensity perpendicular to the cell surface 
at 3 m m above the glass surface and averaged over 2 μm. The effective thickness, deff, identified 
to be the distance between cell surface and the plateau in the average bead intensity.  
Bacterial PEA: cells were intentionally exposed to non-sterile environment in lab and 
allowed to go resultant bacterial infection. 
 
4.2.3 Time-dependent swelling of PCM 
PCM of RCJ-P cells were visualized with PEA. Then 333 mg/mL aggrecan was added to the 
sample. The PEA is then used to monitor the aggrecan-driven extension of the cell coat versus 
time. 
 
4.2.4 Fluorescent protein labeling 
Bovine articulate aggrecan (A1960; >2500 kDa, Sigma Aldrich, St. Louis, MO) was dissolved in 
PBS to reach 2 mg/mL. Histone type II-A (H9250; ~20kDa, Sigma Aldrich, St. Louis, MO) was 
dissolve in PBS to reach 1 mg/mL. Similar procedures used for BSA 66 kDa, AP-4510-60; 
SeraCare Life Sciences, Milford, MA). Fluorescent-labeling was achieved by incubating the 
protein with ATTO NHS ester dye at 2 mg/mL for one hour followed by a Zeba desalting column 





4.2.5 Optical force probe assays 
Optical force probe assays were performed by using a static calibrated optical trap (OT) and a 
programmable stage (ProScan H117; Prior Scientific, Rockland, MA). In a typical experiment, an 
OT holding a 3 μm passivated microsphere was positioned 20 μm outside of the PCM, where it 
could be translated toward and away (orthogonally) to the cell surface at 8 μm/s. The OT was 
paused for 5 seconds at the cell surface (always at a distance of 3 μm) and outside of the matrix. 
The forces on the probe were extracted by using a standard subpixel particle-tracking algorithm 
(102) to find the bead position in the OT. The bead height above the coverslip was ~5μm.  
 
4.2.6 Fluorescent aggrecan exchange assay 
Cells were incubated with the fluorescent aggrecan (333 µg/ml concentration) for two hours at 37 
°C and 5% CO2. Media was replaced with fresh media without aggrecan before imaging the initial 
fluorescent aggrecan distribution with a confocal microscope (FV1000; Olympus, Tokyo, Japan). 
The media was then replaced (within 1 minute) with non-fluorescently labeled aggrecan solution 
(333 µg/ml concentration), and then imaged over time to monitor the fluorescent intensity of the 
aggrecan in the PCM. All fluorescent intensity profiles were taken perpendicular to the center of 
the cells at 3 μm height and averaged over 2 μm. 
 
4.2.7 GFPn labeling of hyaluronan 
Fluorescent labeling of HA was achieved using neurocan-G1 EGFP fusion protein (GFPn) 
expressed by HEK 293 EBNA cells, which were cultured at 37°C and 5% CO2 in DMEM/F12, with 
10% FBS, 1% L-glutamine with 0.1% puromycin (EMD Biosciences, CA) (96, 103). Cells were 




then incubated for 48 hours under serum free conditions. 50 mL of conditioned media was 
collected from a total of 5 culture flasks and concentrated to ~2 mL by centrifugal ultrafiltration 
with a membrane cut-off of 30 kDa (Millipore, MA). The His-tagged fusion protein was purified on 
a HisPur Cobalt spin column (Thermo Scientific, IL). During HA labeling, 10 µL of GFPn was 
added to 90 µL of sample for 15 min incubation.  
 
4.2.8 Chondroitin sulfate digestion assay 
Chondroitinase ABC (ChABC) from Proteus vulgaris (C2905; Sigma Aldrich, St. Louis, MO) was 
used to digest the chondroitin sulfate side chains of aggrecan. ChABC was dissolved in PBS and 
then directly added to cell sample to achieve a final concentration of 0.27 unit/mL. 
 
4.3 Results and Discussion 
4.3.1 PCM swells with increasing aggrecan concentration 
The bottlebrush proteoglycans largely determine the extent of the PCM (together with HA 
length). The PCM can be removed from the cell surface by digestion of the HA with enzymes; or 
it can be collapsed to a thin layer at the cell surface by digestion of the chondroitin sulfate side 
chains on the proteoglycans. Treatment of RCJ-P chondrocyte cells and human mesenchymal 
stem (MSC) cells with chondroitinase ABC (ChABC) nearly eliminates the native 7 μm thick PCM 
on both cell types (Figure 4.2).  Upregulation of versican increases the thickness of PCM on 
smooth muscle cells (116), whereas work in our lab confirms that down regulation of aggrecan 
expression with si-RNA in RCJ-P cells eliminates the PCM detectable by particle exclusion assay 
or optical force probe assays (data not shown). Interestingly, Knudson et al showed that both 





Figure 4.2: Treatment with chondroitinase-ABC (ChABC) at concentration of 0.27 unit/mL 
degrades the PCM in less than five minutes, as determined by erythrocyte PEA (a) before and 
(b) after treatment (5 mins later). The remaining gap between the erythrocytes and the cell 
surface is likely from the surface bound hyaluronan which is still decorated by the protein 




HA and aggrecan, where aggrecan is an essential component for the detectable matrix by particle 
exclusion assays (30, 113). 
 Following a similar approach to that of Knudson but without first digesting the cell coat, we 
examined how the equilibrium thickness of the PCM varies with the solution concentration of 
exogenous aggrecan. For RCJ-P and MSC cells, the PCM width increases until it plateaus at a 
value 250% larger than its original thickness (7.0 ± 0.9 μm; 6.6 ± 1.6 μm; NRCJP=114; NMSC=72).  
For the RCJ-P cells, the PCM thickness reaches a maximum size of 17.8 ± 1.2 μm at cACAN=180 
μg/mL (N=73). For the MSC cells, the critical concentration to achieve maximal extension is 
slightly higher, cACAN=260 μg/mL, with a similarly large extent of 18.0 ± 1.0 μm (N=75). This data 
was obtained by image analysis of traditional erythrocyte particle exclusion assays (PEA) (Figure 
4.1b) of cells after incubation with exogenous aggrecan for two hours (40). We performed time-
dependent studies of the swelling of the PCM (cACAN=333 μg/mL) to confirm that two hours is 
sufficient to reach equilibrium (Figure 4.3b). This is consistent with Knudson et al, who waited 30 




and other cells types (30) using much higher concentrations of aggrecan (2 mg/mL) together with 
exogenous HA (cHA=1 mg/mL). 
It is unlikely that the PCM swelling is due to increased HA synthesis or elongation of HA 
synthase (HAS)-bound HA strands. HA synthesis is regulated through transcriptional activation 
of HASes by growth factors and cytokines or regulated by post-transcriptional events like 
phosphorylation (79). Furthermore, in their reconstituted PCM assays, Knudson et al. performed 
controls comparing the final thickness of the PCM on living and fixed cells, demonstrating the 
same outcome (30, 113). Instead, we infer that the PCM swells as aggrecan binds to free sites 
on the HA, further stretching out of the polymer in an aggrecan concentration dependent manner 
(117, 118). Swelling might also be partly driven by the formation of a polymer brush type scenario, 
since overlap of the grafted HA strands might increase with exogenous aggrecan binding (119, 
120).   
The significant increase in PCM thickness provides the somewhat surprising insight that 
many of the bottlebrush binding sites in the PCM remain available despite the already naturally 
swollen coats of RCJ-P and MSC cells (~7 μm).  Further, for the PCM to expand to such large 
sizes, particularly on the RCJ-P cells which we have shown has no measurable crosslinking in 
the PCM (97), the HA strands must be at least 18 microns in length (~7.5 MDa, 1 
disaccharide~1nm ~400 Da (121)) or it requires that the PCM is comprised in part by free HA 
strands entangled with surface bound strands (122). This is unlikely, however, as several studies 
of biomimetic HA-aggrecan systems suggest that such uncrosslinked multi-layers do not occur 
(123, 124). Lastly, we infer differences between the MSC and RCJ-P cell PCMs by comparing the 
difference in exogenous aggrecan concentration to reach maximal PCM. While the final size is 
similar, higher aggrecan concentration is needed for the MSC, suggesting more free HA binding 





Figure 4.3: (a) PCM thickness measured perpendicular to the cell surface on human bone marrow 
derived mesenchymal stem cells (MSC) and rat chondrocytes (RCJ-P) versus exogenous 
aggrecan concentration. (b) Time-dependent swelling of the PCM after addition of aggrecan 
shows that reaching equilibrium extension requires one hour (cACAN=333 μg/mL). Data is an 




available binding sites in the PCM of RCJ-P cells, and explore how tuning aggrecan concentration 
can affect cell interactions with the surroundings.  
 
4.3.2 PCM maximal extension occurs before bottlebrush saturation 
The spatial distribution of PCM-tethered bottlebrush molecules likely dominates access to 
the cell surface by molecules, nanoparticles, exosomes, and the protrusions/surfaces of other 
cells. Yet, few quantitative data supporting this hypothesis (78). For example, there is no accurate 




most studies, the natural PCM structure is destroyed by fixation before labeling for bottlebrush 
proteoglycans (122, 125). Indeed, despite our own efforts, we have been unable to reliably label 
endogenous aggrecan on living RCJ-P cells using standard methods.  
In an alternative approach, we use fluorescently labeled exogenous aggrecan to study the 
spatial distribution of aggrecan in the PCM. Figures 4.1a and 4.4a present typical examples of a 
cell coat enriched with aggrecan (333 and 39 μg/mL, 2 hrs).  Profiles of the variation of aggrecan 
fluorescence versus distance to the cell surfaces were extracted from the same position of the 
PCM as used for PEA thickness. Confocal images of the PCM taken at a fixed height (3 μm) 
above the coverslip show that at all solution concentrations, the bound aggrecan intensity peaks 
close to the cell surface and then decays rapidly (Figure 4.4b). The curves in Figure 4.4b show 
the average intensity distribution at different concentrations (cACAN=39, 260, 333, 460 μg/mL, 
N~20 for each). Fits to the averaged data reveal an exponentially decaying curve for all aggrecan 
concentrations. At higher concentrations, the intensity decreases less rapidly, possibly due to the 
stretched out HA and its more uniform coverage by aggrecan. At distances beyond the edge of 
the PCM detected by PEA, there is a non-negligible background fluorescence.  
The results indicate that the many of the available binding sites in the PCM are located 
within a few microns of the cell surface. The majority of the incorporated exogenous aggrecan 
appears within 6 μm of the plasma membrane (67, 70, 50, 56, 50, 55% for concentrations 
cACAN=39/ 95/ 180/ 260/ 333/ 460 μg/mL).  
For concentrations of 180 μg/mL and above, more than 50% of the aggrecan are 
incorporated within the inner 35% of the PCM. This is due to a higher density of HA strands in 
this range, whereas a lower number of long HA strands are available to stretch from the cell (103). 
This is visible, for example in Figure 4.1a. The PCM of these cells extends to an average of ~18 
μm under these conditions according to PEAs and is visible out to ~12 μm using fluorescent 




about ~10 μm. In a related work, we use this observation to study the motion of individually bound 
aggrecan molecules as a function of distance to the cell surface. 
 Little difference is apparent between the fluorescent profiles of cells treated with cACAN=333 
versus cACAN=460 μg/mL aggrecan. This indicates that the free binding sites saturate at values 
above 333 μg/mL. Interestingly, the saturation value is much higher than the solution 
concentration needed to fully stretch out the PCM (cACAN=180 μg/mL). This data provides 
evidence that the HA strands stretch to near full extension and then the remaining binding sites 
along the HA are filled by additional bottlebrush molecules.   
 
4.3.3 Fluorescent aggrecan assay reveals free binding sites in PCM  
The equilibrium distribution of exogenous aggrecan shown in Figure 4.4b depends in part 
on the binding affinity of the endogenous aggrecan. Previous studies suggest that in vitro and in 
vivo endogenous aggrecan is very strongly bound to HA due to its reinforcement by link protein, 
which simultaneously binds both to the aggrecan and HA (111). Knudson et al state that the link 
protein stabilized binding of aggrecan is non-dissociating and non-displaceable under 
physiological conditions (126). Our data is consistent with the endogenous aggrecan stability in 
the PCM of RCJ-P cells. For example, exchange of media does not significantly alter the PCM 
size suggesting that the majority of endogenous aggrecan are stably bound and unaffected by 
shifts in aggrecan solution concentration (Figure 4.5).  We therefore estimate that the majority of 
endogenous aggrecan in the cell coats remains localized during the treatments for our studies.  
Thus, the profiles of exogenous aggrecan at saturation (>260 μg/mL) provide a rough map 





Figure 4.4: (a) Fluorescently-labeled exogenous aggrecan at low concentration (39 μg/mL) swells 





the availability of binding sites along a single HA strand, since the data is weighted by the natural 
density variation of HA in the PCM. Fluorescent labeling of the HA shows that the RCJ-P cell coat 
has a higher density of HA near the cell surface which decays exponentially in the absence of 
exogenous aggrecan (103).  Such spatial concentration variation arises in part from the physics 
of adsorbed HA strands (127), but also is likely due to HA polydispersity. As expected, when 
aggrecan-saturated PCMs are labeled for HA, the aggrecan and hyaluronan have nearly identical 




 % change in thickness  % 2 Standard Error  Number of cells 
Positive 
change 
5.49 2.95 27 
Negative 
change 
-7.26 1.72 46 
 
Figure 4.5: The PCM is slightly perturbed by gentle exchange of the media. Measured using 
particle exclusion assays (PEA), we found that PCMs change less than 10% in width (increase or 
decrease). This is approximately the resolution of the erythrocyte PEA. This change may result 
from the loss of endogenous ACAN, whose binding is necessary for swollen PCM; or it could be 
due to loss of HA strands due to the perturbation, or some combination of the two processes. 
Given the small change in thickness, we surmise that most of the endo-ACAN is tightly bound to 




The remarkable implication from these observations is that RCJ-P cells have access to a 
sizable parameter space, cACAN=180 to 333 μg/mL, over which they can maintain a maximized 
PCM thickness, while leaving the possibility to tune the aggrecan concentration and hence the 
binding sites for molecular sequestration (specific and non-specific sites on the bottlebrushes) 






Figure 4.6: Aggrecan co-localizes with hyaluronan in the cell coat. Cells were incubated with 
fluorescent aggrecan (333 μg/mL, 594 nm) for two hours, followed by incubation with GFPn 
(0.15 μM, 488 nm) for 10 minutes. (a) Fluorescent image of aggrecan distribution in the PCM. 
(b) Fluorescent image of HA labeled with GFPn. (c) Profiles of HA and ACAN taken 




4.3.4 Bottlebrush-enriched PCM has reduced mesh size and permeability to 
nanoparticles 
The transport of molecules and nanoparticles to the cell surface is broadly relevant for 
understanding cell-cell communications, drug delivery and tissue homeostasis. The local 
physicochemical environment associated with the PCM is an additional layer worth investigating 
independently from the ECM that will impact these processes.  Previous work has examined the 
permeability of the cell coat to nanoparticles (64, 78, 97, 103, 128, 129), the free diffusion of 
particles in the PCM (64, 103, 128, 129), and quantified the ‘mesh size’ variation in the PCM using 
quantitative particle exclusion assays (qPEA) and optical force probe microscopy (78, 97).  Here 
we use qPEAs to characterize changes in PCM permeability and mesh size after it has been 
saturated with exogenous aggrecan (cag=333 μg/mL). 
In earlier work, we showed that inert nanoparticles, unlike erythrocytes, are able to 
penetrate into the RCJ-P cell coat in a size-dependent fashion (Figure 4.7a). For particles small 




the spatial distribution depends on the particle size (Figure 4.7b). We estimate that the local ‘mesh 
size’ roughly equals a given particle size at the location, deff, where the particle distribution 
plateaus (97).   Thus, we can generate a map of the mesh size versus distance to the cell surface. 
The mesh size decreases in a roughly linear fashion towards the RCJ-P cell surface (Figure 4.8).  
Particles with diameters 500 nm or larger rarely pass into the PCM of RCJ-P and MSC cells. This 
is consistent with our observation that the PCM prevents bacteria from reaching the cell surface 
(Figure 4.8a), raising the question of what role the PCM may play in controlling bacterial and viral 
infections (130).   
The PCM microstructure is dramatically altered by increasing the aggrecan content 
(cACAN=333 μg/mL). Particles 300 nm and larger are unable to enter the PCM (500 nm was the 
previous cutoff), a result consistent with characterization of mesothelial cells by Heldin and 
coworkers (43). The position where 100 nm particles achieve uniform access, e.g. deff, more than 
doubles from 3.5 to 8 μm.  The sharp gradient of particles in the PCM demonstrates that few 
particles (>=100 nm) reach the surface (Figure 4.7b). The percentage of 40 nm particles that 
reach the cell surface appears unaffected by the aggrecan increase (73.2 ± 10.8% vs 70.3 ± 
15.4% relative intensity N=20 (27) and N=11(18), where the second number is the number of total 
measurements made on N cells). However, the percentage of 100 nm particles that reach the 
surface decreases from 38.8 ± 7.8% to 25.7 ± 6.2% (N=32 (44) and N=14 (24)).  Meanwhile, 200 
nm diameter particles do not reach the cell surface in native nor aggrecan-treated cells. Their 
average distance from the cell surface is 3.7 μm in both cases (N=24 (33), N=15 (19)), with low 
relative intensities of 12.2 ± 1.8% and 17.2 ± 2.6% (N=24(32) and N=12(18)). This blockage may 
represent the limit to approach the cell surface due to microvilli on the RCJ-P surface, which we 
estimate extend about ~1-3 μm (103).  As with the native cells, the mesh size in the aggrecan-
enriched PCM decreases linearly toward the cell surface, but more slowly due to the limited 





Figure 4.7: (a) Quantitative particle exclusion assay (qPEA) on RCJ-P cells using 100 nm 
fluorescent beads incubated for 2 hrs with 333 μg/mL aggrecan. The visible gradient in red 
intensity shows how the average local concentration of beads decreases towards the cell surface. 




From these studies, we conclude that cells apparently have the possibility to control their 
very local environment and the accessibility of the cell surface by tuning the bottlebrush content 
in the surface anchored polymer matrix. Although the mesh size of the PCM is large compared to 
molecules, it may be small enough to affect the transport of exosomes (131–133) and 
supermolecular assemblies, including bottlebrush molecules themselves. For example, aggrecan 
is ~300 nm x 80 nm (134)). Increasing bottlebrush density also likely controls interactions with 





Figure 4.8: (a) Bacteria grown with samples of RCJ-P cells show slowed infection due to the PCM, 
which acts as a barrier. The size of the bacteria is larger than the threshold mesh size found for 
native RCJ-P cells using qPEAs (500 nm). (b) Mesh size versus distance to the cell surface: the 
mesh size decreases towards the surface. For swollen PCMs (cACAN=333 μg/mL), red curve, the 
porosity is reduced and it changes more slowly throughout the PCM. Maximum mesh size for 




Furthermore, the high negative charge densities established by chondroitin sulfate side chains 
provide another venue for cells to control passage of positively charged molecules to the cell 






4.3.5 Increasing bottlebrush concentration drives PCM microstucture toward spatial 
uniformity 
Another way to estimate the mesh size in the PCM is via optical tweezer based 
measurement (97, 137). These mechanical measurements relate the equilibrium force, , in 
the PCM to an estimate of mesh size  (more precisely, correlation length in the polymer matrix), 
using the relationship,  , where z is perpendicular distance to the cell surface. This 
prediction is based on a several assumptions discussed and controlled for in an earlier publication 
where we developed optical force probe assays for PCM measurements on RCJ-P cells (97).  
In this study, we measured the equilibrium force at multiple positions throughout the PCM 
of RCJ-P cells with and without incubation with aggrecan. The two force curves in Figure 4.9a 
show little statistical difference in the regions closest to the cell surface (error bars are two 
standard errors), however at further distances the two are distinct, and even more so when the 
mesh size is extracted using the theory (Figure 4.9b).  We measured the equilibrium force at four 
different aggrecan concentrations (0, 39, 95, 333 μg/mL). The results show little difference 
between 0 and 39 μg/mL, but a significant change at 95 μg/mL.  At 333 μg/mL, a value where 
both PEA and exogenous aggrecan experiments show evidence of PCM saturation, the mesh 
size is nearly constant throughout the PCM, barely changing from ~100 nm to 200 nm (between 
3-8 μm).  The data is qualitatively consistent with qPEA data, which also shows a linear decrease 
in mesh size towards the cell surface. Both assays indicate that as the PCM becomes saturated 
with aggrecan, the openings in the PCM become much smaller, reduced to values below 200 nm. 












Figure 4.9: (a) Optical tweezer measured equilibrium force in PCM on native and aggrecan-
saturated RCJ-P cells (cACAN=333 μg/mL, 2 hrs). (b) Estimate of PCM porosity (mesh size) using 
polymer theory and equilibrium force measurement at four different aggrecan concentrations. The 





4.3.6 Unbound aggrecan diffuses swiftly through the PCM 
Next we begin to address the question of how molecular diffusion is affected by the 
presence of the PCM. Both steric hindrance and electrostatic effects are expected to be relevant, 
depending on the size and charge of the diffusing molecules.  Yet the openings in the aggrecan 
saturated cell coat are still quite large relative to molecular scales. Indeed, BSA (Figure 4.10) 






Figure 4.10: Fluorescent BSA (66 kDa, AP-4510-60; SeraCare Life Sciences, Milford, MA) 
penetrates the PCM and reaches to the cell plasma membrane, which is fluorescently labeled 




We focus on two classes of physically and biologically relevant molecules, bottlebrush 
proteoglycans and positively-charged analogs for growth factors. First we examine the diffusion 
of aggrecan, whose large size is similar to the 200 nm cutoff for penetration into the PCM. 
Studying how aggrecan diffuses into the PCM is of great interest both in the context of PCM 
synthesis, as well as PCM and ECM transformation in processes like development (138, 139), 
wound healing (5), central nervous system injury and repair (140), brain plasticity (141), and 
disease (142). 
We monitor the diffusion of label-free aggrecan into the PCM by quantifying the time-
dependent turnover of fluorescently-labeled aggrecan. As in the assays reported in Figure 4.4, 
RCJ-P cells were incubated for two hours with fluorescent exogenous aggrecan (333 μg/mL). 
Then the media was gently exchanged with solution containing the same concentration of ‘dark’ 
aggrecan, e.g. molecules with no fluorescent labeling. The local average intensity dropped 





Figure 4.11: Time dependent replacement of PCM bound fluorescent aggrecan with unlabeled 
aggrecan. (a) Fluorescent profiles of the aggrecan distribution versus time. The first curve marked 
‘Before’ is taken after the fluorescent-aggrecan is removed and replaced with media (no 
aggrecan). Then the buffer is exchanged with a media containing the same concentration of 
aggrecan but with no fluorescent label (cACAN=333 μg/mL). (b) Integrated aggrecan intensity (over 
entire PCM) versus time. A reproducible drop occurs in the first step and then the aggrecan 
turnover proceeds linearly. (c) Monitoring aggrecan change at fixed positions in the PCM reveals 





intensity at each time step shows an initial rapid decrease in intensity of ~23% (N=17, 3 
experiments), that is followed by a slower, linear decrease in intensity (Figure 4.11b). Controls 
involving the exchange of the media with aggrecan-free media showed no significant drop in the 
aggrecan intensity within the first minute (N=15, 3 experiments), while the sharp drop was 
reproducible.   
In the first minute, the aggrecan turnover occurs uniformly at distances from 2-12 μm 
(Figure 4.11a, c).   Thereafter, at distances 7.5 μm and greater, little apparent change occurs. 
The majority of the remaining dynamics takes place at the inner, tighter portion of the cell coat, 
where according to the qPEA assays, the average mesh size is less than 100 nm. Hence we 
observe that the initial replacement and diffusion of dark-aggrecan into the PCM is rapid and 
penetrating to the cell surface. However complete replacement of the aggrecan requires more 




In these experiments, the dark-aggrecan molecules competitively bind with the 
fluorescently labeled aggrecan. In the presence of high concentrations of dark-aggrecan, the 
turnover of the fluorescent population is expected to be quite fast. The dissociation constant and 
off rate of the G1-module of aggrecan is kd=20 nM (25) and  koff= 2.5E-3 s-1 (143). The slower 
turnover in the inner regions of the PCM likely arises from a combination of factors that impact 
the kinetics. First, in these tighter spaces where the average opening is less than the average 
dimension of the aggrecan, diffusion inward will be slowed. Like the 100 nm particles that have a 
reduced concentration in the inner regions, the aggrecan accessibility may also be reduced. 
Secondly when the fluorescent aggrecan is released, in regions where there is a high 
concentration of possible binding sites, there is a higher probability that it will rebind, slowing the 
loss of fluorescence.  
 The fact that aggrecan is able to diffuse quickly into the aggrecan-enriched PCM is 
significant, considering its reported extended size is on the order of ~300 x 80nm or larger. In 
solution, aggrecan forms a globule, which according to dynamic light scattering has a 
hydrodynamic radius of ~200 nm (144). Yet, we have shown that 200nm particles are mostly 
localized to the edge of the PCM at ~11.5 μm from the cell surface in aggrecan-treated cells (333 
μg/mL) and significantly hindered from entering the PCM of the native RCJ-P cells at distances 
closer than 6 μm to the cell surface. It is possible that the asymmetry of aggrecan as well as its 
flexible, globular properties enables freer passage through the cell coat.       
 
4.3.7 Electrostatic sequestration of positively charged ~20 kDa molecules in the PCM 
In this final section, we study the interaction of small positively charged molecules with the 
high-negatively charged landscape generated by the chondroitin sulfate-rich PCM. Looking for 





Figure 4.12: (a) Fluorescent histones (cyan) are barely detectable within the PCM of native 
RCJ-P cells (cH=232 μg/mL for 20 mins). (b) The majority of histones bind very close to the 
surface and are largely injested by the cells. Labeling of the HA in the PCM with GFPn confirms 
as expected the PCM extends beyond the region where histones bind. (c) In aggrecan-enriched 
PCMs (cACAN=333 μg/mL), the histones bind strongly to the PCM, whose presence is confirmed 
by PEA (cH=232 μg/mL for 20 mins). The PCM is thinner than histone-free measurements, 
indicating a collapse driven by crosslinking (see Figures 4.13, 4.14). (d) GFP and histones co-




questions regarding the passage of growth factors, cytokines and chemokines through 
hyaluronan-aggregate rich PCM and ECM (35).  Small molecules should not be sterically hindered 
by the PCM since it still maintains >100nm openings even during bottlebrush saturation. Yet, there 
is evidence that PCM can sequester molecules via non-specific and specific binding to the 
sulfated chains in bottlebrush (35). Here we focus on the possible role of electrostatic interactions.  
 For this exploratory study, we use an inexpensive surrogate for growth factors, histone 
proteins, which have similar charge and size to growth factors (145). Figure 8a shows an image 
of RCJ-P cells incubated with fluorescently labeled histones (cH=232 μg/mL, 20 mins). Very little 





Figure 4.13: Histones bind to exogenous aggrecan in the cell coat of RCJ-P cells. Measurement 
of the fluorescently labeled aggrecan and histones shows co-localization of the molecules. (a) 
Fluorescent image of aggrecan-swollen PCM (333 μg/mL, 2 hours, yellow) with (b) histones 
added (232 μg/mL for one hour, light blue).  (c) Profiles of exog-ACAN and histones in the PCM. 
The zero is arbitrary and does not indicate the cell surface. Histones were left in solution when 
taking image, hence the slightly higher background. The binding of the histones reduces the 




outside the cell was visible, while uptake onto the plasma membrane and nucleus was significant.  
To distinguish histones, which are bound close to the cell surface versus those taken inside of 
the cell, we fluorescently labeled the PCM’s hyaluronan using GFPn (Figure 4.12b). The majority 
of the histone appears inside of the cell or close to cell surface. A very small signal appears in the 
PCM region from approximately ~2-6 μm.  
We repeated the same experiment in aggrecan-enhanced PCMs (333 μg/mL, 2 hrs) 
followed by exposure to histones (cH=232 μg/mL, 20 mins).  Strong binding between the 
exogenous aggrecan and histone is reflected by the brightly labeled PCM (Figure 4.12c).  Far 
less of the histones are taken up by the cells, showing that an aggrecan-rich PCM sequesters 
positively charged molecules and reduces their uptake by the cell.   
There is a direct correlation between the fluorescent aggrecan, the HA (Figure 4.12d), and 
the histone distributions (Figure 4.13) in aggrecan-enriched samples (333 μg/mL). Most samples 
showed evidence of HA crosslinking and resultant PCM shrinkage in the presence of histones 





Figure 4.14: Evidence for PCM crosslinking by histone proteins, whose multiple positive charges 
could simultaneously bind multiple aggrecan molecules, crosslinking the PCM. This leads to the 
formation of fibers and bundles around and between the cells. In both images, the samples 
where incubated with aggrecan (333 μg/mL) for two hours, followed by replacing with media 




(Figure 4.4b vs Figure 4.12d and Figure 4.13) suggests that the PCM is collapsed from an average 
is reduced from ~12 μm to ~6 μm. Evidently the positively charged histones can act as 
crosslinkers between the aggrecan molecules (Figure 4.14). Similar effects have been shown by 
crosslinkers in a PCM model systems (146–148). 
 Interestingly, in control experiments to further demonstrate that the histones localize to the 
chondroitin sulfate side chains on aggrecan, we attempted to remove the histones by their 
degradation with chondroitinase ABC (ChABC). Instead, we found that histone-enriched PCMs 
could no longer be fully digested (see Figure 4.15). This result confirms that the histones bind to 
the chondroitin sulfate chains so strongly that they block the enzymatic activity of ChABC. 
Repeating these experiments on the native RCJ-P cells incubated with histones showed similar 
results: the PCM remained intact despite minimal visual evidence of histone sequestration (Figure 






Figure 4.15: (a) Fluorescent histone treatment of aggrecan-incubated RCJ-P cells shows 
significant visible labeling of the PCM. (cACAN=333 μg/mL, 2 hours; cH=232 μg/mL, 20 minutes) 
(b) The histones partially block digestion of the PCM by the enzyme ChABC (0.27 unit/mL) for at 
least 30 minutes. Without histones, the PCM is removed in less than five minutes. (c) Profile of 
the histone distribution perpendicular to the cell surface before and after ChABC treatment. 
There is a decrease in the histone intensity and slight degradation of the cross-linked fibers 







Figure 4.16: (a) Fluorescent histone treatment of RCJ-P cells does not show significant visible 
labeling of the PCM; however the PCM remains, as shown by PEA. (232 m g/mL, 20 minutes) 
(b) Digestion of the PCM by the enzyme ChABC (0.27 unit/mL, 20 minutes) is blocked by the 
presence of the histones. (c) Profile of the histone distribution perpendicular to the cell surface 





This is compelling evidence that the chondroitin sulfates on native endogenous aggrecan 
and exogenous aggrecan in the PCM sequester positively charged histones, and at high 
bottlebrush concentrations, significant reduction in histone uptake is a consequence. 
 
4.4 Conclusions and Outlook 
These studies provide quantitative illustrations of how changes in bottlebrush 
proteoglycan concentration in the PCM can affect the transport of nanoparticles to the cell surface 
as well as the sequestration of positively charged molecules. Diffusion of the bottlebrushes 
themselves still occurs through saturated pericellular matrix despite the dimensions of the 
molecule and its negative charge. Further, several experiments independently imply that the 
native PCM of RCJ-P and MSC cells in vitro are sparsely populated by endogenous 
bottlebrushes.  
The sparse population of bottlebrushes points to the possibility for cells to use surface-
tethered proteoglycans to monitor native cell surface accessibility or to concentrate and sequester 
biomolecules like growth factors. Mechanics could be altered this way as well. For the cell types 
studied here, a special regime exists where the PCM appears fully stretched, but where the 
porosity and molecular interactions can be tuned significantly by varying the solution 
concentration between 180-333 μg/mL. 
Although these studies do not recapitulate in vivo conditions, where the PCM is likely 
compressed by surrounding tissue, they provide compelling data that modulation of bottlebrush 
proteoglycan distribution in the PCM and indeed in the ECM can affect tissues physical properties 
dramatically.   
There are many important directions to pursue in future work. Immediately relevant are 




and its possible effects on cell. For example, looking at whether BMP-2 is sequestered and 
concentrated to high enough concentrations to drive differentiation of stem cells would be an 
excellent example of how PCM can be utilized by cells as a molecular reservoir. Further, given 
the observation that PCM can significantly reduce the molecular uptake of histone proteins 
suggests the need to investigate possible filtration effects that might eliminate harmful molecules 
and/or interfere with proper cell function by removing necessary molecules. More generally, our 
studies demonstrate how important it is for researchers to be cognizant of possible PCM effects 
in studies of drug delivery vehicles, exosomes or any study looking at size-dependent endocytosis 
or phagocytosis.  In the longer term, the ability of the PCM to dynamically transform is relevant 
for understanding cell-cell and cell-ECM interactions, for example in migration and proliferation. 
Finally, interesting strategies for the bioengineering of scaffolds or tissues could be taken from 
the studies here. For example, generic seeder cells that produce PCM could be planted in 
matrices and utilized to control local production and concentration of growth factors.  To conclude, 
the pericellular matrix is often broadly neglected; yet its presence adds another dimension of 






Hyaluronan Mediated Cell Adhesion 
 
5.1 Overview 
Hyaluronan polymer has been studied in its connection with cell adhesion events more 
and more in recent years. It has been shown to impact the migration and proliferation of the cells, 
impede cell connections in synaptogenesis, impact cancer cell malignancy, and play a critical role 
in cell rearrangements during embryogenesis. Moreover, many cancer-focused studies have 
focused on the signaling role that HA plays (mostly in oligosaccharide form) via the 
transmembrane receptor CD44, which transmits a chemical signal to the cell interior. However, 
inspired by the unusual HA distribution on migrating cells, a more mechanical view of the HA’s 
potential impact on adhesion events also pervades the literature. It has been speculated that the 
accumulation of HA matrix at the trailing edge of a migrating cell reduces the adhesion strength 
at that end so the cell can detach from the substrate easier. At the same time, less HA matrix at 
the leading front of the cell entails a stronger adhesion to the substrate and anchor that part of 
the cell stronger than the rear of the cell. Cell utilizes this gradient of adhesion strength to migrate. 
It is also speculated that HA modifies the adhesion between cells during proliferation since 
proliferating cells have been documented to have more HA production than during other cell 
cycles. During the dividing stage, the cell might produce a significant amount of HA that again 
might weaken the adhesion between parent and daughter cell, and thus separate them apart. 
With all these speculations, we incorporate various techniques to elucidate the effect of HA in cell 
adhesion. 
This chapter summarizes our investigation of the role that cell-surface anchored HA plays 




of cell adhesion strength measurements using a hydrodynamic assay, the state of focal 
adhesions, hyaluronan patches under the cell, and their spatial correlation and impact on the 
contact area of the plasma membrane with the substrate. A series of self-consistency checks and 
controls were performed to check that the HA impact is directly mechanical rather than indirectly 
impacting the state of the focal adhesions or that the enzymatic treatments used adversely 
change adhesion strength. Integrating the outcome of these experiments, we provide the most 
thorough study and compelling evidence to support the hypothesis that hyaluronan mechanically 
mediate cell adhesion through mechanical repulsion.  
 
5.2 Materials and Methods 
5.2.1 Cell culture and sample preparation 
See section 3.2.1 
 
5.2.2 Glass coverslip coating 
During spinning disk assay, round cover glass (Neuvitro, Vancouver, WA: GG-25-1.5) is used, 
and 25x25 mm #1.5 glass coverslip (VWR: 48366-249) is used for all other experiments. 
All glass coverslips are first cleaned by sonicating the coverslips first with water for 5 
minutes and then with 100% ethanol for another 5 minutes. They are then washed with PBS 
(VWR: 97062-732) twice to get rid of residual ethanol. The coverslips are put on top of 100 μl of 
protein solutions on a piece of parafilm inside biosafety cabinets for 1 hour to absorb proteins 
onto the coverslips. Fibronectin (Human, Life Technology: 33016015) is diluted with PBS to the 
concentration of 50 μg/ml and collagen (Type I, Rat, Life Technology: A1048301) is diluted in 20 
mM acetic acid to the concentration of 33 μg/ml. The collagen incubation is kept in the dark. After 




mg/ml BSA for 30 minutes by the same method. The coverslips are ready to use after washing 
again with PBS. The protein-coated coverslips can be kept in 4°C fridge with PBS for 3 days if 
not used immediately. 
 
5.2.3 GFPn production and use 
See section 3.2.3 
 
5.2.4 Transfection of fluorescent paxillin 
The mCherry-paxillin plasmid is a gift from T. Barker (Georgia Tech, Atlanta, US) and GPF-paxillin 
plasmid is a gift from K. Salaita (Emory University, Atlanta, US). 
The cell density of 80% confluency is optimal for transfection in 24 wells plate (Corning: 
3524). The optimal seeding numbers are 1.5x104 cells for RCJ-P and Hs578T, and 4 x104 cells 
for PC3 in the 1.9 cm2 cell growth area in the plate for 16-18 hours.  
Lipofectamine LTX DNA transfection reagent (ThermoFisher: A12621) is used for 
fluorescent paxillin transfection following the product protocol. First dissolve 0.5-1 µg of DNA into 
100 µl Opti-MEM® Medium with 0.5-1 µl of PLUSTM Reagent for 5 minutes. Afterwards, 1-1.5 µl 
of Lipofectamine® LTX Reagent is added to the solution for 25 minutes before adding the solution 
into the cell media in wells. To seed the cells into Teflon rings for imaging, the DNA reagent 
solution is sucked out and temporary put away after DNA incubation of 18-20 hours. Incubation 
with 500 µl of trypsin is used to detach the cells from the 24 wells plate. After counting, the normal 
density of cells is plated into the Teflon rings and the DNA reagent solution is added back to the 






5.2.5 Reflection Interference Contrast Microscopy 
The ventral topography of cells is monitored by Reflection Interference Contrast Microscopy 
(RICM). Polarized light from epi-illumination is used to image the cells. Constructive and 
destructive interference between light reflected off the cell and the cover glass results in light and 
dark fringes. The shade of the fringes depends on the distance between the cell and the substrate 
(149). Although the RICM image is complicated by the presence of additional interfaces and the 
use of incoherent light, the quantitative trends remain the same. Under RICM, locations where 
cell made direct contact with the substrate appear as dark patches on an otherwise grey 
background. 
Cells seeded in Teflon rings are first imaged with RICM, the same cells are then repeatedly 
imaged every 5 minutes for over an hour when incubated with bacterial hyaluronidase. Ventral 
topographies are compare on the same cell for the first 30 minutes of enzyme incubation. 
For a quantitative analysis of the RICM images, pixel intensity under the cell are gathered 
and binned into histogram using ImageJ. Freehand selection tool is first used to highlight the 
outline of the cell, and the histogram function in the analysis section analyzes the pixel intensity 
and displays the statistics. The standard deviation and average intensity of the intensity histogram 
distribution are used to compare the states of the cells’ ventral topography.  
 
5.2.6 Spinning disk apparatus 
The spinning disk apparatus is used to measure cell adhesion strength. The setup consists of a 
fluid-filled cylinder in which a disk containing the sample spins. When high enough hydrodynamic 
shear applied to the cells, they detach from the substrate. The system applies a linear range of 
forces, correlated with the distance to center of rotation, to the cells while maintaining a constant 




The glass slide with cells is attached to the spinning disk device by creating vacuum on it 
by design. Submerging the apparatus into chamber filled by PBS with 2 mM of Dexrose (Sigma 
G7021), the sample is spun for 5 minutes at room temperature. After the spin, the cells are fixed 
with 4% ethanol free formaldehyde. The samples are ready for imaging after mounting the cover 
glasses onto microscope slides with ProLong Diamond with DAPI dye at room temperature for 
more than 6 hours. 
 
5.2.7 Adhesion strength measurement 
On the slides, 61 fields (60-100 cells/field before spinning) with various radial distance to the 
center are imaged using a Nikon TE300 equipped with a Ludl motorized stage, Spot-RT camera, 
and Image-Pro analysis system. Comparison of the adhered cells left on surface to the population 
at the center produces the fraction of adherent cell at different positions. The radial distance of 
the locations can be converted to the shear stress on the cells with the equation 𝜏 = 0.8𝑟 ∗
𝜌 ∗ 𝜇 ∗ 𝜔,, where 𝜌, 𝜇, 𝜔 are the fluid density, fluid viscosity and angular velocity of the disk 
respectively. The fraction of cells remain on the surface after spinning is then fit to a sigmoidal 
curve 𝑓 = /0
12345	[8 9:9;0 ]
, where 𝑓  and 𝜏  are the experimental adherent cell fraction and disk 
surface shear stress and 𝑓=, 𝑏, and 𝜏?= are the fitting zero-stress cell fraction, decay slope and 
inflection point (150, 151). The adhesion strength of the cell is defined to be the shear stress for 
50% detachment. 
For comparison of different state of HA matrix, the percent change of adhesion strength 
is the fraction of the change in adhesion strength to the control cells. The N reported for spinning 
disk experiments is of the number of individual samples done, which contains more than 




5.4.5, all the conditions of HA matrix state are only compared with the control cell samples done 
on the same day. 
 
5.2.8 Enzyme treatment digesting PCM  
There are various classes of hyaluronidase (HAdase), or Hyals, based on their mechanism of 
action (24). Two different classes of HAdase, from bacteria and bovine, were used on the cells in 
this experiment. Both of the enzymes degrade HA predominantly. They also have limited ability 
to digest Chondroitin (Ch) or Chondroitin Sulfate (CS) but at a much lower rate (24). There is a 
common misconception that bacterial HAdase only targets HA, but it has been proven not that 
case. It still degrades Ch and CS but at an even lower rate than the other HAdase type (152). The 
structures and action modes of the two Hyal types are different. The vertebrate Hyals degrade 
HA through a non-processive endolytic process, which generates a range of HA oligomers with a 
wide spectrum of size-dependent biological activities. On the other hand, many bacterial Hyals 
appear to degrade HA through initial non-processive endolytic bites for high molecular weight HA 
followed by exolytic processive degradation on the smaller chains. For the degradation of Ch and 
ChS, only the non-processive endolytic method is employed. The process produces the same 
size unsaturated Ch/ChS-disaccharides (24). 
The enzymes are dissolved in PBS and then directly added to cell sample to achieve final 
concentration of 0.08 mg/ml for bovine HAdase (type I-S, Sigma: H3506) and 7.5 un/ml for 
bacterial HAdase (Hyaluronate lyase from Streptomyces hyal, Sigma: H1136). Enzyme is left in 
the cell culture media for 30 minutes to digest the PCM around cells. Interfacial HA matrix labeled 
with GFPn showed a decrease of more than 80% in intensity after HAdase incubation showing 





5.2.9 Myosin II inhibition 
Blebbistatin (Sigma: B0560) is reconstituted in DMSO following the manufacturer’s instruction. It 
binds to ADP-Pi on myosin and locks myosin in ADP-Pi phase and stops motor activity. Cells are 
seeded onto cover glasses for 18-20 hours before 20 μM of blebbistatin is added into cell media 
for 30 minutes according to protocols for myosin II inhibition (153–155). 
RCJ-P cells’ phenotype changed within 30 mins of incubation with blebbistatin, and began 
to reduce contact area to the substrate. During the comparison experiment, blebbistatin was 
added in with bacterial HAdase to the cells for 30 minutes, and the adhesion strength was 
compared with that of the cells just incubated with blebbistatin for 30 minutes. 
 
5.2.10 HA synthase suppression  
4-methylumbelliferone (4-MU) blocks HA biosynthesis by its ability to sequester cytosolic UDP-
glucuronic acid (UDP-GlcUA) (156). Additionally, 4-MU effects a pronounced reduction of HA 
synthase 2 (HAS2) transcription but by mechanisms that are currently unknown (79, 156, 157). 
After suspension of the cells by trypsin, the cells were incubated with 2 mM of 4-MU for 4 
hours. The cells attached to the substrate during that time. They were not as spread out as control 
cells but formed tethers at the cell edges (still look healthy). Use GFPn and see no significant 
amount of HA are around nor under the cells in 6 hours of incubation 
For the comparison experiment, both sets of samples have their 4-MU containing media 
aspirated out, washed with 2 mL of sterile PBS, and replaced with fresh complete culturing media 
with and without 2 mM of 4-MU. GFPn was used to visualize and found HA around and under the 
cells within 1 hour in the samples without 4-MU and none in samples with 4-MU. Adhesion 





Fig. 5.1: (a) HA matrix under fixed RCJ-P (green). (b) Spatial anti-correlation between HA matrix 





5.3.1 Hyaluronan is organized in patches at the cell-substrate interface 
We previously demonstrated that neurocan-link-protein attached to GFP (GFPn) 
specifically labels hyaluronan on living cells, and used it to characterize the pericellular matrix 
(see Ch. 3 and 4). Above the glass substrate and surrounding the cells, there is a continuous 
distribution of HA that comprises the PCM on several cell types including chondrocytes (RCJ-P), 
prostate cancer cells (PC3), and breast cancer cells (Hs578T). At the interface of the cell and the 
substrate, not surprisingly, the structure is different because it coexists with adhesive plaques. 
Confocal microscopy reveals a patch-like HA distribution for all three cell lines (see Figures 5.1, 
5.4, 5.5). After adding bacterial or bovine hyaluronidase (HAdase) into the cell culture solution, 




verified that the loss of fluorescence does not arise from photo-bleaching of the GFP, e.g. the 
GFPn labeled cells were imaged at the same frame rate in the same conditions without exposure 
to HAdase and the fluorescence signal remained with minimal bleaching. 
 
5.3.2 Spatial anti-correlation of focal adhesions and HA patches 
Previous studies have demonstrated the spatial segregation of FAs and chondroitin 
sulfate, where it was implied the CS is that found on the chondroitin sulfate rich bottlebrush 
proteoglycans (CSPG) associated with HA (36). Immunofluorescence studies also showed that 
HA and HA receptors co-localize with versican, a member in the CSPG family (37), and the HA 
receptors have a negative correlation with one of the focal adhesion proteins, paxillin, at the cell-
substrate interface (39). These results hinted the ventral HA patches could be separated by FAs. 
In preparation to consider how the HA patches might coordinate with focal adhesions in mediating 
the mechanics of cell adhesion, the spatial localization of HA versus FA was investigated on the 
cell lines studied in our lab. The results are summarized below.  
We start with RCJ-P cells because they are the model cell line that the Curtis lab has 
optimized all of its biophysical assays on and it is a system we know well. The other two cell types 
reported here are both cancer cell lines, chosen in part because HA expression and presence is 
correlated with the onset on many types of cancer. Furthermore, the prostrate PC3 cells were 
selected because of the classic papers by Ricciardelli reporting PCM-dependent cell migration 
(41). The breast cancer cell line, Hs578T, was chosen because it is a highly malignant, highly 
migratory phenotype that produces very large amounts of hyaluronan (80). It is also a cell line 
studied by one of our collaborators, Dr. Paraskevi Heldin, who ultimately will work with us to 





5.3.2.1 RCJ-P cells 
RCJ-P cell binding to untreated glass produces elongated, distinct FAs (see Figure 5.2a). 
We were able to visualize these FAs on living RCJP cells by transfecting them with GFP paxillin, 
which localizes at the focal adhesion complex and is widely used as a FA marker. After 
transfection, the efficiency was about 20% of the cells expressing the GFP-paxillin, which was 
typical according to our collaborator Prof. Salaita from Emory University, who graciously provided 
the GFP-paxillin vector for transfection. There was no change in phenotype of the cells that 
expressed GFP-paxillin. Both the fluorescent paxillin transfection and vinculin immunostaining 
showed, similar to fibroblasts and other cells bound to glass, the majority of the FAs are located 
at the edge of the cells, while the ones in the middle of the cell are smaller and less elongated 
(N>30 from various methods).  
In order to simultaneously visualize HA and FAs, we originally tried to label FAs with a 
non-green fluorescent label via transfection, e.g. mCherry paxillin (gift of Dr. Tom Barker’s lab). 
Unfortunately, despite efforts at optimization, the mCherry paxillin transfection protocol did not 
label the FA well on the RCJ-P cells. The transfection success rate of mCherry paxillin was lower 
than the 20% transfection rate with the GPF paxillin. Even in the few cells expressing mCherry 
paxillin, the FA labeling was dim and difficult to discern because the background fluorescence in 
the cell was high (see Figure 5.2b).  
Ultimately, we resorted to immunofluorescent staining of fixed RCJ-P cells using a red 





Figure 5.2: Live RCJ-P cells (a) GFP-paxillin shows elongated FA concentrated at edge of cell. 




due to hydration issues. However, we found that the HA at the interface remained (to what extent 
is less clear, although it appears to be similar in structure as on living cells as shown by comparing 
directly – data not shown). Figure 5.1 shows a typical image of the outcome of this fixation 
procedure. The interfacial hyaluronan and the FAs are in distinct regions, separated for the most 
part, especially when the FAs are large as on the edges of the cell.  In their related Nature paper 
in 2014, (mostly not focused on hyaluronan however), Paszek and Weaver (88) showed strikingly 






Figure 5.3: (a) GFP-paxillin on live PC3 cells shows FA more punctate than RCJ-P. (b) The 




5.3.2.2 PC3 prostate cancer cells 
Our studies show that the PC3 prostate cancer cell line produces far less distinctive 
adhesive plaques than the RCJ-P cells. Indeed, labeling via transfection with GFP-paxillin (Figure 
5.3a) or alternatively, immunofluorescence with vinculin antibody (Figure 5.3b) revealed punctate 
focal complexes rather than the mature FAs displayed by RCJP cells. Also, comparing the HA 
patches under cell, labeled by GFPn, on PC3 (Figure 5.4) and on RCJ-P (Figure 5.1) showed the 
separating spaces between the HA patches on the PC3 cells are not as elongated as the ones 
under RCJ-P cells. Also there are more HA excluded zones under PC3 than RCJ-P cells. (N=20) 
Although only shown one image here, fluorescent vinculin was imaged on more than 30 
fixed PC3 cells. However, the transfection of fluorescent paxillin, GFP or mCherry, did not yield 





Figure 5.4: Confocal image under live PC3 cells (a) GFPn labeling HA matrix. (b) GFPn labeling 




5.3.2.3 Hs578T breast cancer cells  
The breast cancer cell line Hs578T was transfected with mCherry paxillin so that FAs and 
hyaluronan could be visualized simultaneously. The results were impressive, with a typical image 
shown in Figure 5.5. The same spatial separation apparent in the RCJ-P cells is seen for the 
Hs578T cells as well. Clear anti-correlation of the green interfacial HA and the extended FAs is 
apparent. Different from the other cell lines, the HA appears to gather closer to the edges of the 







Figure 5.5: mCherry-paxillin (red) and GFPn (green) shows spatial anti-correlation between FA 




5.3.3 Topographical variations at the cell-interface decrease after hyaluronan removal 
To examine the impact of HA on the topography of the cell-substrate interface, we 
employed reflection interference contrast microscopy (RICM) (149, 158), also sometimes called 
interferometric reflection microscopy (IRM) (159). This interferometric technique provides 
qualitative (and quantitative if desired) information regarding variations in height between the cell 
and the substrate. Variations in intensity correspond to variations in topography, where typically 
darker shades of grey reflect a portion of the cell close to the substrate and brighter regions 
indicate a portion of the cell further. For example, FAs tend to appear as black strips in RICM, 
and comparison of RICM with immunofluorescent labeling of the FAs shows overlap (Figure 5.6). 
The inherent interferometric nature of the technique means that the scale repeats itself in shades 





Figure 5.6: (a) RICM image on live RCJ-P cell and (b) GFP-paxillin labelling of the FA on the 




we do not provide absolute information regarding cell topography at the interface but just relative 
changes.  
 
5.3.3.1 Topography of RCJ-P cell plasma membrane  
This interferometric approach was used in our studies to compare the cell membrane 
roughness at the interface (amount of variation in topography, e.g. intensity) before and after 
enzyme degradation of hyaluronan. The different shades of grey in the RICM images reflects 
various distances of the cell membrane to the substrate. When imaging the RCJ-P cells with 
RICM, a high degree of variation in intensity was visible, for example in Figures 5.6 and 5.7a. A 






Figure 5.7: RICM images of live RCJ-P cells showing the distance between cell and substrate (a) 




Next, the same cells were exposed to bovine HAdase (30 min) while monitoring with 
RICM.  Movies of RCJP cells showed the intensity variations reducing over that time period and 
becoming nearly uniform (see Figure 5.7) and much darker, indicating that the cell membrane 
approached the substrate and became significantly less ruffled. Repeating the experiment and 
just analyzing before and after images of the same cells in RICM, it was estimated that the 
intensity variations diminished significantly in 95/100 cells examined. To quantify the change in 
the ventral topography of the cells after enzyme treatment, the pixel intensities under one cell are 
sorted and analyzed by the image process program, imageJ. The standard deviation of the pixel 
intensity under one cell shows the roughness of the topography. When there are more rises and 
falls under the cell, there will be a wider range of bright and dark fringes in the RICM images, and 
therefore yield a larger standard deviation of the pixel distribution (Figure 5.8). Quantitative 
analysis of the RICM images of the standard deviation of the pixel intensity for each cell before 





Figure 5.8 Pixel intensity histogram under single cell before and after bovine HAdase treatment 




HAdase treatment showed that the variation decreased by an average 114.13 from 610.82 ± 9.52 
to 496.69 ± 14.26 (see Figure 5.9). And the average mean of the pixel intensity decreased by 402 
units, from 13008 to 12606, demonstrating the cells became closer to the substrate. For 
reference, Figure 5.8 shows the pixel intensity histogram of the top right cells in Figure 5.7 before 
and after enzyme treatment. The mean intensity decreased by 145.81 unites and the standard 
deviation of the distribution decreased by 473.57 units. 
Our interpretation of this data is that HA patches at the cell-substrate interface deform the 
cell membrane, pushing it up and away from the substrate through steric and possibly electrostatic 
repulsion, making it difficult to form adhesive bonds and also placing a strain on the bonds that 
exist. The gaps generated by the interfacial hyaluronan are eliminated when HAdase digests the 
polymer, as reflected by the uniform intensity which reflects reduction of the rippling at the 
interface; and by the darkening on the intensity which reflects the approach of the cell surface 





Figure 5.9: The average pixel intensity standard deviation before and after bovine HAdase 




5.3.3.2 Topography of PC3 cells 
A similar strategy to examine topography of the cell membrane of PC3 cells was pursued. 
RICM images for the PC3 cells revealed that the gap was not as rough as the RCJ-P cells. The 
quantitative analysis of the RICM images showed the standard deviation of the pixel intensity 
histogram before and after bovine HAdase treatment for 20 minutes does not change significantly. 
The average changed from 236.86 ± 13.87 to 237.45 ± 16.71 (see Figure 5.9). And the average 
intensity decreased by only 21 units, from 7449 to 7428, which is 5% of the average intensity 
change on RCJ-P cells of 402 units. So comparing to RCJ-P cells, the topography under PC3 
cells did not change significantly after HAdase treatment. 
 
5.3.4 HA matrix decreases the adhesion strength 
The key experiment to look at how hyaluronan physically mediates adhesion is to quantify 




(rather than via signaling or some other indirect mechanism).  The first quantitative measurements 
of cell adhesion strength versus hyaluronan were made for this thesis work. The key 
measurement technique is the hydrodynamic spinning disk apparatus (150, 151). With this 
technique, the average adhesion strength of cells can be determined by identifying the 
hydrodynamic shear force required to detach 50% fraction of the cells from the substrate (see 
Materials and Methods for a full review of this technique).  
In this study, measurements of the cell adhesion strength of two HA-rich cell types, RCJP 
and PC3 are compared with measurements of the same cell’s adhesion strength after the 
pericellular matrix has been altered (e.g. removed) by HAdase enzyme treatment. Two different 
types of HAdase were compared (bacterial and bovine HAdase – see Materials and Methods). 
Further, two different exposure times to the enzyme were used for comparison: short time 
exposure, 15-30 minutes and longtime exposure, 2 hours. The outcome of the experiments is 
summarized in Figure 5.9 & 5.10 and Table 5.1. For each condition, at minimum triplicates were 
acquired, where each component of the triplicate often is comprised of several measurements. 
The total number of individual measurements included in the reported outcome is reported as N, 
where each N is comprised of an experiment involving 1000s of cells. 
In every experiment, the adhesion strength of the given cell type was measured as a 
control. As discussed at the end of this chapter, this is important because the adhesion strength 
of the control cells appeared to drift over time, while the comparative results remained relatively 
(qualitatively) consistent. As reported below, we find that the adhesion strength of the RCJ-P cells 
(on glass substrate) was consistently higher than the adhesion strength of the PC3 cells adherent 





Figure 5.10: Histogram of projected cell area (a) control cells (CN), (b) after bovine HAdase (HV), 




 (N=43) while for PC3, the value was typically 70% lower, with an average of 82.94 ± 4.78 
dyne/cm2 (N=27). The weaker adhesion is consistent with smaller adhesive plaques of the PC3 
cells and their more rounded, less extended phenotype. How hyaluronan changes the state of 
these adhesion strengths is the subject of the rest of this section. 
 
5.3.4.1 Evaluation of cell area as a criterion to apply spinning disk 
Since the hydrodynamic shear stress depends on cell shape and area, we rely on the 
premise that for a given cell type and condition, the cells are consistently similar in area and shape 
(both in the same sample as well as between different conditions). To justify the relative 
comparison of the cells before and after HAdase enzyme treatment, we performed controls to 
look at the average cell shape and area before and after enzyme exposure.  
Before reviewing the results, it is worth considering how a decrease versus increase in 
cell area might impact the apparent adhesion strength. Assuming approximately constant volume 









the material extended from the surface. In that case, if the cell adhesion strength due to binding 
at interface is constant, it would make it appear as if the adhesion strength decreased. The 
opposite would be true for an increase in cell area. An increase in cell area would result in a 
fictitious apparent increase in adhesion strength. For the work here, our hypothesis is that 
removing HA will decrease mechanical repulsion and therefore increase the cell adhesion 
strength; all things left the same in shape, we would therefore expect a higher hydrodynamic 
shear force to remove the cells. Therefore, an increase in area would interfere with interpretation; 
a decrease in cell area would obscure the results slightly by reducing the effect, but it would not 
be responsible for increased adhesion.  
Calcein AM was used to label the area of the live cells. From images of more than 600 
RCJ-P cells, the area did not increase significantly after incubation with bovine HAdase nor 





Table 5.1 Summary of the measured adhesion strengths (and standard error) of HA-rich cells, 





area of 487.05 ± 15.66 μm2 (N=339) for control RCJP cells to 437.97 ± 16.93 μm2 (N=230) for 
bovine HAdase treated cells and 369.92 ± 16.90 μm2 (N=106) for bacterial HAdase treated cells 
(see Figure 5.10). Since the projected area did not increase, any measured adhesion strength 
increase cannot result from an artefact arising from the cell area change.  
The data presented in Figure 5.10a and Figure 5.11 shows that before HAdase treatment, 
RCP-J and PC3 cells have a relatively narrow distribution of areas, sufficient (if not perfect) for 
using spinning disk apparatus, that is the standard error of the cell area is less than 5% of the 
average. Another cell type, Hs578T breast cancer cell line, on the other hand was found to have 
too much variation in shape and size and therefore was not a good candidate for these 






Figure 5.12: Comparison of adhesion strength of RCJ-P cells for control (CN), bovine HAdase 
(HV) and bacterial HAdase (HC) treatments. Left and middle are short time (15-30min) exposure, 




5.3.4.2 Spinning disk results consistently show that interfacial HA weakens cell adhesion 
The adhesion strength values reported above for the cells under standard conditions, can 
then be compared to the same cell types’ adhesion strengths after HAdase treatment. For short 
15-30 incubation periods with bovine HAdase, the adhesion strengths of both the RCJP cells and 
PC3 cells increased: RCJP by 33% and PC3 by 44%. The results are summarized in Figure 5.12 
and 5.13.  In more detail, the adhesion strength of control cells for RCJ-P and PC3 were 265.08 
± 7.75 dyne/cm2 (N=12) and 71.39 ± 4.50 dyne/cm2 (N=8) respectively. The experiments with two 
different HAdase on PC3 cells were done at the same time, so the adhesion strength on the 
control cells is the same for both comparison conditions. The adhesion strength after bovine 
HAdase treatment were 353.23 ± 11.69 dyne/cm2 (N=18) and 102.42 ± 14.24 dyne/cm2 (N=6).  
Students t-test shows that the differences are statistically significant where p<0.001 for 
RCJP and p<0.05 for PC3.Similar measurements were made using bacterial HAdase at short 
incubation times. RCJ-P adhesion strength increased more than 12% after HA was depleted 





Fig 5.13: Comparison of adhesion strength of PC3 cells for control (CN), bovine HAdase (HV) 
and bacterial HAdase (HC) treatments (short and long term enzyme treatments); * p<0.05, ** 




5.9 and 5.10, the absolute numbers of the adhesion strength for each condition/cell type were as 
follows: for the control cells for RCJ-P and PC3 were 300.23 ± 17.87 dyne/cm2 (N=24) and 71.39 
± 4.50 dyne/cm2 (N=8) respectively. The adhesion strength after bacterial HAdase treatment were 
336.95 ± 22.26 dyne/cm2 (N=14) and 91.75 ± 7.52 dyne/cm2 (N=8). Students t-test shows the p-
values were p<0.1 for RCJP and p<0.05 for PC3. 
Measurement of adhesion strength after a longer exposure to bovine HAdase (2 hours) 
also led to a similar outcome to that of shorter incubation times: the chondrocyte RCJ-P adhesion 
strength increased by 31%, similar to the 33% increase reported above for the shorter incubation 
time. The adhesion strength of PC3 rose 65%, slightly more than the 44% increase associated 




strength of control cells for RCJ-P and PC3 were 212.03 ± 17.70 dyne/cm2 (N=7) and 68.30 ± 
3.80 dyne/cm2 (N=10) respectively. The average adhesion strength after bovine HAdase 
treatment is 278.41 ± 15.41 dyne/cm2 (N=9) for RCJ-P and 111.61 ± 6.51 dyne/cm2 (N=10) for 
PC3 cells. Students t-test shows that the differences are statistically significant where p<0.01 for 
RCJP and p<0.001 for PC3. 
Before we realized that bacterial HAdase is less specific, digesting chondroitin sulfates as 
well, we also studied the change in adhesion strength of PC3 cells after 2 hours treatment with 
bacterial HAdase. The PC3 adhesion strength increased by ~38%, slightly larger than the 29% 
increase seen after short time treatment with bacterial HAdase, shown in Figure 5.10. This 
experiment was only done once. The adhesion strength of control cells for PC3 was 73.31 ± 2.67 
dyne/cm2 (N=4). The adhesion strength after bacterial HAdase treatment was 101.24 ± 4.66 
dyne/cm2 (N=4). The p-value is p<0.001. 
 
5.4 Discussion 
The goal of the spinning disk measurements and accompanying experimental data is to 
quantitatively test the hypothesis that the presence of HA at the cell-substrate interface reduces 
external force needed for cell detachment by mechanical repulsion. More specifically, we 
hypothesized that the presence of HA polymer at interface will exert a repulsive force and in some 
yet to be determined way, reduces the total cell adhesion strength to the substrate.  
Here we compare the data with the hypothesis, and discuss the outcome and 
interpretation. We find for all conditions used (cell type, type of HAdase, exposure time), the cell 
adhesion strength of the cells qualitatively increases when hyaluronan is removed. The results 










strength is depicted in Figure 5.14. The model assumes that the total adhesion strength of the 
cell adhered to the surface is due to the sum of the adhesive forces of the focal adhesions minus 
the repulsive force of the pericellular matrix/HA patches. If these two separate forces can be 
superimposed, they partially cancel, reducing the total adhesion strength of the cell to the surface 
in the presence of HA. The hydrodynamic spinning assay identifies the hydrodynamic shear stress 
necessary to overcome this net adhesive force. When the hyaluronan repulsion is reduced by the 
removal of the HA, we assume that the average focal adhesion does not immediately respond 
but remains constant. Hence, the net adhesion strength is greater in the absence of HA and a 
larger hydrodynamic force is necessary to remove the cells.  
Applying the proposed model, as depicted in Figure 5.14, to the analysis of the results 
presented in Tables 5.1 and 5.2, we find that it explains the results (e.g. increased adhesion 
strength due to HA removal) and supports the hypothesis that HA exerts a mechanical repulsive 





Figure 5.14: Simple mechanical interpretation of the increase of adhesion strength. Left (black 
box) is on control cells with HA matrix under cell and the right (purple box) is when HA matrix 
degraded. Red is the FA. Green arrow represents the repulsive force from HA matrix. Blue arrow 




made in order to apply the model are carefully explored below and justified with the support of 
additional control experiments.   
The assumptions include the following: on the time scale of the experiment, the focal 
adhesion strength (red arrow) does not significantly change in response to the HAdase treatment. 
The second is that HA exerts a repulsive force (green arrow). The third is that the HA force and 
adhesion force can be superimposed such that we effectively treat the cell like a ‘point particle’. 
The fourth is that the non-specific adhesion energy between the cell and the substrate is minimal 










5.4.1 Assumption I: Focal adhesion strength does not significantly change in response to 
the HAdase treatment 
5.4.1.1 FA area remains constant during and after HAdase treatment 
Focal adhesions are renown as complex, mechanosensitive elements of the cell. At the 
beginning of this work, we had no idea whether change in the state of the PCM/HA patches would 
alter the FA size, composition, and adhesion strength in some way. We therefore sought to 
characterize directly the apparent response of the FAs, and control for any possible change in 
adhesion strength (increase) resulting from FA dynamics rather than a depleted repulsive polymer 
force.  
We sought to characterize whether the total focal adhesion force could increase in 
response to an effect from the enzyme treatment affecting the integrin or other components of the 
cell; we also aimed to characterize whether the size and/or average number of FAs changed in 









the gap between portions of the plasma membrane and the substrate. Focal adhesions were 
monitored on living RCJ-P cells expressing fluorescent paxillin. After 15-30 minutes of incubation 
with bovine HAdase (the HA-specific enzyme), the FA area showed minimal change. The average 
FA area before and after HAdase treatments are 0.86 ± 0.04 μm2 and 0.84 ± 0.04 μm2 (N= 3 cells) 
respectively. Figure 5.15 shows the FA size distribution before and after. We found that on 
average most FAs remained the same size or if anything, tended on average to slightly decrease 
in size (see Fig 5.16). Figure 5.17 shows a few blown up images of a particular FA and a 
comparison of their shape before and after HAdase. 
A similar tactic was tried on the PC3 cells. However again the weak intensity of the FAs in 
transfected PC3 cells (fluorescent paxillin) made analysis tricky. We therefore assume that a 






Figure 5.17: FA labeled by GFP-paxillin before (red) and after (green) bovine HAdase treatment 




5.4.1.2 Adhesion strength is not increased due to myosin II contractile activity 
As discussed in the background, FA size does not necessarily correspond to adhesion 
strength in mature focal adhesions. Therefore, we performed a second control to interfere with 
the contraction controlled adhesion strength. Myosin-mediated tension within the lamellar actin 
cytoskeleton drives changes in FA composition and helps the FA reach maturation (72, 89, 160) 
and it also is involved in mechanosensitive responses of the cell. We therefore blocked myosin II 
activity with the drug, blebbistatin, and looked at the adhesion strength of the RCJP cells before 
and after treatment in the presence and absence of HAdase. 
We hypothesize that if no large response of the FA driven by myosin activity takes place, 





Figure 5.18: Adhesion strength change on RCJ-P with blebbistatin treatments (BL) and after 




similar. Although the RCJ-P cells’ myosin activity was suppressed by blebbistatin myosin II 
inhibitor, the adhesion strength increased by 19% after removing HA matrices with bacterial 
HAdase treatment for 30 minutes. The adhesion strength of the blebbistatin-treated cells was 
229.39 ± 4.48 dyne/cm2 (N=10) and after treating with bacterial HAdase, the adhesion strength 
of those blebbistatin-treated cells was 273.18 ± 13.58 dyne/cm2 (N=10). We could only do a 
relative comparison because blebbistatin treated cells have a smaller area and hence changed 
(decreased) adhesion strength, as indicated by the absolute numbers. However, the percentage 
change between the control and the HAdase treated cells (with and without myosin II blocking) is 
within a few percent. Figure 5.18 and summarizes the outcome. The relative percentage change 
was near identical, consistent with the interpretation that the increased adhesion to the substrate 
after HAdase treatment is not driven by contractile activity.  
 
5.4.1.3 Adhesion strength remains constant after enzyme treatment of cells not expressing HA   
To better test the assumption that incubation with the HAdase enzyme does not alter cell 




cell type lacking HA expression and surface associated HA. The rationale is that if treatment with 
HAdase in this scenario increases the adhesion strength, then it means the adhesion strength 
increase does not require HA matrix and our hypothesis is wrong. 
Chinese Hamster Ovary (CHO) cells do not have a significant amount of HA (161). After 
treating the CHO cells with bacterial HAdase for 15-30 minutes, the adhesion strength decreased 
by 0.9%, which was negligible. The adhesion strength of the control cells was 285.08 ± 8.37 
dyne/cm2 (N=13) and after treating with bacterial HAdase for about 30 mins, the adhesion strength 
was 282.62 ± 13.57 dyne/cm2 (N=8).  
  
5.4.1.4 Signaling through HA cell surface receptors is under investigation 
HA receptors on the cell membrane were shown to be able to transfer biochemical signals 
via binding HA oligosaccharides (24). The shorter HA polymers or monomers degraded by the 
enzymes might bind to the receptors and activate a signaling pathway to alter the adhesion 
behavior. In order to downplay that possibility, the shorter enzyme incubation time (15-30 minutes) 
was designed to measure the adhesion strength before cell could react to the signaling and 
concentrate the source of adhesion strength change to the mechanical interference. 
To further investigate the possible signaling from the HA oligosaccharides generated by 
the HAdase, we also planned to compare the adhesion strength of cells with and without 
exogenous HA oligosaccharides added to the solution. Work towards this experiment, e.g. 
controls, were performed but the final hydrodynamic assays have not been completed. The 










how it impacted the PCM and interfacial HA since oligo-HA is known to competitively bind to CD44 
and displace polymeric HA. The experiments showed that the PCM and the interfacial HA labeled 
with GFPn remained after 2 hours of incubation, and the concentration of interfacial HA increased 
slightly (Figure 5.19).  
For the prostate cancer cells, adding HA oligosaccharides dissipates the PCM around the 
cells and HA patches under the cells in about 3.5 hours. Reducing the incubation time to two 
hours led to similar results as the RCJ-P cells; the interfacial HA remained intact (Figure 5.20). 
It’s possible that oligo-HA generated by HAdase at the cell interface could act differently because 
it may be that they cannot diffuse under the cell to competitively bind in the control experiment. 
This seems unlikely though, since BSA can diffuse under the RCJP cells (size 66 kDa) while the 
oligo-HA is only 200 Daltons. It’s also possible that the binding kinetics is very different in the 
confined space where the polymeric HA is far more compressed and confined in mobility. 









HAdase, we have shown that it does not significantly impact the interfacial HA and more 
importantly, it doesn’t appear to bind to the CD44 receptors, through which signaling could occur.  
However incomplete this approach may be for the reasons identified above; it is still 
valuable to look at how adhesion strength changes before and after addition of oligosaccharides. 
So if the oligosaccharides do not cause changes to the focal adhesion, the adhesion strength 
should remain after 30 minutes of incubation with them. The experiment is not done in time for 





Figure 5.21: HA labeled by GFPn under (a) 4-MU treated cells and (b) 2 hours after 4-MU washed 
off showing HA patches grown back under cells. Images are on the same RCJ-P cell using the 




5.4.2 Assumption II: HA can exert a repulsive force at the cell-substrate interface 
Studies show that polymer brushes and in particular, end-grafted hyaluronan films are 
well-described as elastic polymer brushes (123). Compression of the end-grafted polymer brush 
by a flat surface leads to an exponential increase in force dependent on the compression distance 
(123). Based on polymer physics and the electrostatics from the negatively charged HA, the 
compressed HA matrix under the cells is predicted to thus exert a repulsive force between the 
cell and substrate, which will be removed when the HA is digested.  
 To test this assumption of HA repulsive force, we attempted to compare the adhesion 
strength of cells with no HA due to a drug-induced suppression in HA synthesis versus cells where 
the HA synthesis was increased by removing the drug.  4-methylumbelliferone (4-MU) has been 
used as a low toxicity, high potency inhibitor of HA biosynthesis (162). 4-MU sequesters one of 
the main sugar monomers of HA to inhibit HA synthesis. Unfortunately, it also impacts the 




After trypsinization, which removes the PCM, RCJ-P cells were plated in the presence of 
4-MU. Therefore, the entire adhesion process occurred in the absence of HA at the interface. 
(Separate controls show that the PCM is detectable with RBC PEAs after about 3 hrs).  Imaging 
with GFPn showed the absence of ventral HA patches throughout exposure to 4-MU both at the 
interface and around the cell body (i.e. no PCM). After washing and replacing with fresh culture 
media, RCJ-P cells grew back a partial HA matrix in 2 hours.  
We compared the adhesion strength of RCJ-P cells exposed to 4-MU in this fashion for 
4+2 hours with RCJ-P cells exposed to 4-MU for 4 hours and then allowed to grow with no 4-MU 
for two more hours. The outcome was surprising. Against our hypothesis that the cells with fresh 
HA at the interface should produce a weaker adhesion strength, instead the 4-MU free cells had 
a 15% stronger adhesion. The adhesion strength of 4-MU cells was 230.17 ± 13.73 dyne/cm2 
(N=18) while the adhesion strength for the cells with HA was 264.64 ± 12.46 dyne/cm2 (N=23). 
This result was inconsistent with our hypothesis that HA matrix repels the cells from the 
substrate. The experimental setting with the 4-MU was new to our lab, so more control studies of 
the 4-MU effect on cells still need to be done. The following are two control experiments that was 
done and more to do. The adhesion strength measurements were done 6 hours after seeding, 
and the HA regrowth process was initiated at 4 hours after seeding. The time points were chosen 
because the sequestration of HA monomer sugar need to be minimized since the sugar is 
essential for other functions of the cell but at the same time, the cell adhesion strength should be 
in a stable state so that the HA effect can be isolated. Control experiments showed seeding RCJ-
P with 4-MU for 4 hours and 6 hours had similar adhesion strength. The adhesion strength at 4 
hours was 185.25 ± 30.15 dyne/cm2 (N=2) and at 6 hours was 184.91 ± 25.68 dyne/cm2 (N=3) 





Figure 5.22: Adhesion strength change on RCJ-P with 4-MU treatment (4MU) and after HA growth 




experiment was only done once due to time constraint and needed to be repeated for 
confirmation. No conclusion should be made before the confirmation of the time required for 
adhesion strength stabilization. 
Comparing the with control cells, the 4-MU treated cells seeding for 4 hours did not spread 
out well on the substrate. The morphology of the 4-MU cells was more round, which was usually 
associated with cells of weaker adhesion. However, 4 hours after seeding, the adhesion strength 
of the control cells and cells seeding with 4-MU were similar. The adhesion strength of the control 
cells and 4-MU treated cells were 149.83 ± 12.18 dyne/cm2 (N=5) and 143.41 ± 26.41 dyne/cm2 
(N=3) respectively (Figure 5.22). This control was also only done once so further confirmation is 
needed before a conclusion can be made. If one assumes that in fact the rounder cells have a 
higher shear stress acting on them, then the same results in adhesion strength would be 
consistent with the 4-MU cells being more tightly bound to the surface. This actually would be 
consistent with the idea that cells with HA present (control cells) should have a weaker adhesion 




the ‘sicker’ cells which are possibly experiencing side effects from the drug, should have a weaker 
adhesion not stronger.  
More studies of the change on FA in the presence of 4-MU are required. Fluorescent 
paxillin in the transfected cells can be used to compare the state of FA with and without 4-MU 
present. The size, shape and location of the FA can be monitored at different time points of the 
adhesion as well.  
 
5.4.3 Assumption III: The HA force and adhesion force can be superimposed 
The transmembrane FA anchors the cytoskeleton to the substrate by binding to both 
structures. The anchoring force is transmitted to the whole cell body through the cytoskeleton 
system. The repulsive force from the HA matrix push on the cell membrane it’s in contact with. 
Both forces act on the whole cell so they can be superimposed.  
 
5.4.4 Assumption IV: The non-specific adhesion energy between the cell and the substrate 
is minimal compared to the total adhesion energy 
PC3 cells have the same adhesion strength on collagen surfaces with and without BSA, 
which blocks the non-specific binding between cell and the substrate. It indicates that the 
difference in adhesion strength does not arise from the variations in non-specific interactions. 
Repeating the same control for RCJP on glass seemed poorly defined, since the entire surface 










5.4.5 Full disclosure: Other possible issues in approach and the analysis used to study 
HA-mediated cell adhesion 
5.4.5.1 Drift of adhesion strength over time and issues with reproducibility 
During the experiments, the adhesion strength of the control cells was not constant, but 
there was no particular trend for the shift. Cell culture conditions were kept at constant to the best 
of our ability but there might still be some variations in the cells’ condition that caused this 
inconsistency. However, with the changing adhesion strength on the control cells, the majority of 
the experiments showed an increase of adhesion strength after the HA matrix depletion. During 
the summer of 2016, both cell lines’ adhesion strength for control cells are abnormally higher and 
during that period, depleting HA matrix did not increase the adhesion strength. After an overhaul 









media and reagents, switching to a new box of round cover glasses, the adhesion strength of the 
both cell lines decreased, although it did not go to the previous level, the adhesion strength 
increased again after the enzyme treatment. We speculated that it could be that the high adhesion 
strength reached the regime that it is so high comparing to the repulsive force the HA matrix can 
exert so that taking away the repulsive force did not pose a significant increase in the adhesion 
strength. 
 
5.4.5.2 HAdase calibration not done quantitatively 
The enzyme activity was not quantified so some of the discrepancies in the adhesion 
strength change might come from the different enzyme activity caused by different batch 





Figure 5.25: Adhesion strength of control and bovine HAdase treated cells RCJ-P in PBS (+/+) 




by making sure the HA matrix labeled with GFPn disappeared after 15 minutes of enzyme 
incubation and there’s no drastic change in the cell phenotype, such as cell shape, size or viability. 
 
5.4.5.3 PBS lacking ions impacts FA response 
The 5 minutes in which shear stress of the spinning disk was applied to the cells, they 
were in a PBS solution without the divalent ions, Ca2+ and Mg2+, for FAs. When the cells were 
spun in the PBS with those ions, PBS (+/+), the adhesion strength of RCJ-P appeared much 
higher than the cells spun in the PBS without Ca2+ and Mg2+, PBS (-/-) (Figure 5.25). The adhesion 
strength of the control cells in PBS (+/+) was 2.5 times higher than that in PBS (-/-) and they are 
690.05 ± 16.82 dyne/cm2 (N=10) and 276.06 ± 11.56 dyne/cm2 (N=43) respectively. And the 
bovine HAdase treatment of 15 minutes decreased the adhesion strength by about 20% to 553.38 
± 25.82 dyne/cm2 (N=7). However, those experiments were done during the time with especially 
higher control adhesion strength and the enzyme treatment didn’t change the adhesion strength. 




treatments increased the adhesion strength. More experiments are to be performed to make sure 
the reproducibility of this result. Also, future spinning disk experiments should be done in the PBS 
(+/+) providing FA the necessary condition for proper functions. 
 
5.4.5.4 Role of extracellular matrix proteins in hyaluronan mediated adhesion  
Although all the experiments on PC3 cells were performed on collagen coated surface, 
experiments on RCJ-P cells were done on untreated glass surfaces. RCJ-P cells adhere and 
spread well when seeded onto glass so we have continued seeding them on glass for the 
adhesion experiments. However, for a more well-defined adhesion experiment, the cells should 
be seeded on surfaces covered with extracellular matrix proteins. Preliminary studies of RCJ-P 
cells on fibronectin surfaces began at a time in our lab when reproducibility of previous results 
was very difficult. Hence we were unable to systematically pursue the somewhat shocking results 
of this experiment.  
Comparing the adhesion strength of RCJ-P cells on glass, collagen coated and 
fibronectin-coated surfaces, adhesion strength on fibronectin was 86% higher than on glass or 
collagen, on which the adhesion strength was similar to on glass. The adhesion strength of control 
cells on glass, collagen and fibronectin coated surfaces are 312.228 ± 25.23 dyne/cm2 (N=3), 
288.37 ± 9.55 dyne/cm2 (N=3) and 579.57 ± 5.60 dyne/cm2 (N=3). Students t-test shows the p-
values were p=0.43 for collagen surface and p<0.001 for fibronectin surface when comparing to 
glass surface (Figure 5.26). Repeated experiments are needed to confirm this result. 
Treating the RCJ-P cells seeded on fibronectin with bovine HAdase and bacterial HAdase, 
the adhesion strength decreased rather than increased. The adhesion strength of control cells for 









adhesion strength after bovine HAdase treatment is 458.01 ± 19.17 dyne/cm2 (N=7) and after 
bacterial HAdase treatment is 453.80 ± 20.77 dyne/cm2 (N=6). Students t-test shows that the 
differences are statistically significant where p<0.01 for RCJP and p<0.001 for PC3 (Figure 5.27). 
This is the exact opposite of the results reported for RCJ-P cells on glass. Searching for a self-
consistent explanation of these results, the one possible scenario that we could identify involves 
adhesive interaction between the interfacial HA and the fibronectin. If adhesion takes place, this 
could help further anchor the cell to the surface. Indeed, in studies of early onset of cell adhesion 
before focal adhesion formation, Geiger et al proposed that HA is useful for anchoring cells to 
surface (163). To our knowledge, HA does not bind directly to fibronectin. Various HA-binding 
proteins are known to interact with fibronectin, the most likely candidate of which is the bottlebrush 
CSPG, aggrecan (on these cells).    It has been shown that aggrecan CSPG can bind to fibronectin 
(164). It might be that with the higher concentration of fibronectin on the substrate, the binding 
between the HA matrix and fibronectin increased the overall adhesion strength. When the HA 
matrix was digested, the binding force from the matrix also disappeared. So although HA digestion 





Figure 5.27: Adhesion strength of RCJ-P cells decreased after bovine HAdase (HV) and bacterial 





extra binding force with the fibronectin over-powered the gain, and the overall adhesion strength 
decreased. 
 
5.4.5.5 Cell shape and size control 
The heterogeneity of the cells in their sizes and shapes results in less accurate and 
consistent adhesion strength measurements. It would be best to control the cell-substrate contact 
area and cell shape (151) using micropatterened surfaces. Efforts were made to devise 
micropatterning on the substrate in the Curtis, but it is still in progress. Nevertheless, the results 
presented here are quite good evidence that HA repulsion changes cell adhesion strength, and 
provide at least a qualitative evidence that the mechanics is likely to alter the adhesion strength 






5.5 Conclusion and Outlook 
In the work presented in this chapter, we have illustrated the presence of HA patches 
under cells and a spatial anti-correlation between the FA and those HA patches. The anti-
correlation was shown on three different cell types, rat’s chondrocyte cells RCJ-P, human prostate 
cancer cell PC3, and human breast cancer cell Hs578T. This spatial anti-correlation of FA and 
HA is robust for it is observed not only in these different cell types but also in mammary epithelial 
cells (88). With the RICM images showing the space under the cells disappear after the HA 
patches are digested, we have demonstrated the HA matrix under the cells created gaps between 
cell and substrate. The gap created by HA might decrease the possibility of integrin binding 
forming because the comparison to the place where cells in contact with the substrate coincide 
with FA. Also, the fact that the space between the cell and the substrate can be removed by 
depleting HA matrix suggests that HA exerts a force on the cells that push the cell off the 
substrate.  
Quantitative measurement of the adhesion strength showed the cell adheres stronger after 
the HA matrix was removed. This fits our hypothesis that the HA matrix exerts a repulsive force 
under the cell to orchestrate the complex adhesion event along with the anchoring force by the 
FA. It brings us back to the inspirational model of the adhesion. We provide evidence that at the 
part of the cells lacking HA matrix under cell has stronger adhesion strength than the other areas 
with average or more amount of HA accumulation. So that when the actomyosin system contracts 
during cell migration, the weaker end of the cell will detach from the substrate while the other end 
will stay attached. Continuous contraction of the cell will pull the cell toward the stronger adhere 
end and move the whole cell in that direction. However, the mechanism of which HA matrix 
facilitate the weaker cell adhesion still need to be fleshed out. Our analysis is based on several 




needs to be tested further. Also that the integration and mechanosensing of the FA to the HA 
matrix state should be looked at more carefully.  
In this present studies, uncertainty has raised because of the enzyme activity. The 
unquantified enzyme activity, the possible effect of the enzyme to the cell, and the degraded HA 
matrix adding an extra layer of signaling molecules have all introduce more noise in our study. 
Future investigation should utilize tools to genetically modify the expression of HA synthase, HA 
receptors or the CSPG for a more elegant experiment.  
Another area to pursue is the interactions between HA patches and the underlying ECM. 
We had some intriguing but complicated result that RCJ-P cells adhere stronger on surfaces 
coated with fibronectin than on collagen-coated surfaces. The adhesion strength on the 
fibronectin is 86% larger than that on the collagen-coated surface or undefined glass surfaces. 
While the adhesion strength increases after HA degradation on collagen surfaces and glass 
surfaces, the adhesion strength decreases significantly after HA removal on the fibronectin 
surfaces. Our first thought was that there are bindings happen between the HA matrix under cell 
and fibronectin, which add an additional anchorage to the cells which over-powered the effect of 
HA presence. So degrading the HA, in the end, decreases the overall adhesion strength. Future 
adhesion experiments should be done on well-defined surfaces.  
Surface ligand density was shown to affect the adhesion strength (165). A possible 
experiment is to decrease the ligand density and decrease the adhesion strength. After depleting 
the HA matrix with enzyme, compare the adhesion strength change. If HA patches around cell 
exert repulsive force, then the change between the two surfaces should be the same. Controls 






Chondroitin Sulfate Mediated Cell Adhesion 
 
6.1 Overview 
Previous studies have suggested that bottlebrush CSPGs (also known as lecticans or 
hyalectans) are relevant at the cell-substrate interface (37, 166). Further, it is known that lecticans 
are a major component in the pericellular matrix and interact strongly with hyaluronan via the HA 
binding domain, the link module and reinforcement by link protein. In many scenarios, it has been 
demonstrated that lectican’s large size and high negative charge make them strongly repulsive 
both sterically and electrostatically; for example, neural crest cell migration (142), cancer 
malignancy (167) and synaptogenesis (15). These observations combined with our novel 
technique to look at HA-mediated cell adhesion prompted the investigation reported in this 
chapter: to begin to quantify if and how lectican impacts cell adhesion strength. Indeed, our 
general strategy was to look for straightforward approaches to modify the PCM and quantify 
changes in adhesion strength. After HA modification, lectican was the next most straightforward 
candidate. Given the constraints of this PhD period, the enzymatic degradation of chondroitin 
sulfate (CS) via ChABC and aggrecan via aggrecanase was the most practical approach. 
Ultimately, however, we intend to use the gentler, non-enzymatic approach of genetic modification 
of the expression of HAS, CD44 (or relevant HA receptor) and lectican. 
As will become clear, the outcome of this study proved to be surprising in multiple ways. 
On one hand, the preliminary data looking at how enzymatic degradation with ChABC impacts 
cell adhesion strength, suggested a robust and reproducible effect of increased adhesion, even 
larger than that found when removing hyaluronan. We originally interpreted this result as 




repulsive force. Their digestion could significantly reduce that force, and led to an increased cell 
adhesion strength (see model Ch. 5). The increased adhesion strength when compared to 
hyaluronan digestion was hypothesized to be reasonable since HAdase would only remove HA, 
not the bottlebrushes. If lectican remained trapped at the interface after HA digestion, they could 
still have a significant impact. On the other hand, HA without bottlebrushes is expected to have a 
far of an impact, as exemplified by the shrinkage of RCJ-P PCM from 7microns to ~1um after 
ChABC digestion of the cell coat.    
Yet, to provide further complementary evidence for the proposed interpretation that 
bottlebrush removal significantly increases the adhesion strength, we arrived at null results 
despite our multipronged efforts to demonstrate concretely that lectican exists at the cell–
substrate interface continuously yielded null results. For quite some time, however, this did not 
detract us because similar efforts failed in labelling the lectican in PCM where we are 100% 
confident it is present (see Ch.4). Finally, as the rationale and modeling of the system evolved, 
we concluded that confinement of the large bottlebrush proteoglycans at the cell interface will 
require big ruffles and gaps, with tremendous topographical variations (at least ~100-200 nm for 
just one lectican). Therefore, we turned to RICM to look at the impact of enzymes including both 
HAdase and ChABC. We were quite surprised to find, as reported below, that HAdase 
consistently reduces the topography and creates a uniform interface, while ChABC performs 
intermittently, reducing the topography of only a sub-fraction of the cells. Hence, the results 
presented in this chapter do not integrate as nicely as the similar study of HA-dependent 
adhesion. Instead, we provide evidence that lectican may not exist at the cell-substrate interface 
(in cell culture) at all, at least on RCJ-P cells.  
In light of this, it is very surprising that ChABC enzymatic degradation has a serious impact 
on cell adhesion strength, increasing it by more than 30%. This chapter reports the data as it 





6.2 Materials and Methods 
6.2.1 Cell culture and sample preparation 
See section 3.2.1 
 
6.2.2 Enzyme treatment  
Chondroitinase ABC (ChABC) from Proteus vulgaris (Sigma: C2905) was used to digest the 
chondroitin sulfate side chains of aggrecan. ChABC was dissolved in PBS and then directly added 
to cell sample to achieve a final concentration of 0.27 unit/mL.  
Aggrecanase, ADAMTS-4 recombinant, was purchased from EMD Millipore. It was diluted 
into 20 mM Tris-HCl at pH 7.5 with 10 mM of CaCl2 and 0.05% Brij detergent. Concentrations of 
0.1 μg/ml to 10 μg/ml were tested but no change in the PCM thickness was observed by PEA. 
 
6.2.3 Spinning disk adhesion assay 
See sections 5.2.6 and 5.2.7 
 
6.2.4 Immunocytochemistry with antibody CS56 
Cells were fixed for 15 minutes in 4% formaldehyde, washed and blocked with 10% donkey serum 
for 60 minutes. Anti-CS primary antibody (CS-56, Abcam: ab11570) with 10% serum was 
incubated overnight at room temperature. After washing, secondary antibody, donkey anti-mouse 
IgG Alexa 405 (Abcam: ab175658), was added for 60 minutes, and then mounted in fluorosave, 




6.2.5 Fluorescently labeled histone 
Histone type II-A (H9250; ~20kDa, Sigma Aldrich, St. Louis, MO) was dissolve in PBS to reach 1 
mg/mL. Fluorescent-labeling was achieved by incubating the protein with ATTO NHS ester dye 
at 2 mg/mL for one hour followed by a Zeba desalting column (89882; Thermo Scientific, 
Waltham, MA) to remove excess dye.  
 
6.3 Results 
6.3.1 Cell adhesion strength increases after chondroitin sulfate enzymatic degradation  
Inspired by the other reports on the effect of various lectican on the adhesion process, we 
found the cell adhesion strength increased after ChABC treatment, consistent with the naive 
expectation that removal of lecticans would remove a large repulsive force and increase 
measured adhesion strength. For RCJ-P cells, incubating the cells with ChABC for 15 minutes 
increased the adhesion strength by 38%, where the control cells had absolute strengths of 265.08 
± 7.75 dyne/cm2 (N=12) to 366.93 ± 21.25 dyne/cm2 (N=6). After incubating the cells with ChABC 
for 2 hours, the adhesion strength increased by 35% and went from control cells 212.03 ± 17.70 
dyne/cm2 (N=7) to 285.67 ± 9.56 dyne/cm2 (N=6). The changes are statistically significant with p-
value being p<0.001 and p<0.01 respectively. 
Just as the experimental design in Ch.5, the adhesion strength measurements were 
executed using two different enzyme incubation times, a shorter incubation time of 15 minutes 
and a longer incubation time of 2 hours. The 2 hours incubation time was chosen because that 
time was required during the PCM manipulation experiments reported in Ch.4. However, to focus 
on the physical mechanics of the CS affecting cell adhesion and avoid cell adjusting its adhesion 
in response to the PCM change or signaling from enzyme residues, a shorter 15 minutes 




Table 6.1: Adhesion strength percent change (comparing to control adhesion strength) of various 





control experiment to fully degrade and collapse the PCM around the cells above the surface. 
For PC3 cells, incubating the cells with ChABC for 15 minutes increased the adhesion 
strength by 28%, from control cells 109.47 ± 7.51 dyne/cm2 (N=9) to 140.20 ± 9.73 dyne/cm2 
(N=6). After incubating the cells with ChABC for 2 hours the adhesion strength increased by 45%, 
went from control cells 68.30 ± 3.80 dyne/cm2 (N=10) to 99.37 ± 3.83 dyne/cm2 (N=13). The 
changes are also statistically significant with the p-value being p<0.05 and p<0.001 respectively. 
Same as in section 5.3.4, control to test if the cell projected area increase after ChABC 
treatment was done because increase in cell projected area will give a false illusion of adhesion 
strength increase. Images of more than 300 calcein-AM-labeled RCJ-P cells showed the area did 
not increase after 15 minutes incubation with ChABC. The average area of the cells decreased 
from 544.48 ± 28.58 μm2 (N=181) on control cells to 441.22 ± 27.04 μm2 (N=164) on ChABC 
treated cells. Therefore, the adhesion strength increase was not an artefact from cell area change 
(If anything, one might expect the adhesion strength will decrease). However, the FA area change 






Figure 6.1: Histogram of projected cell area (a) before and (b) after ChABC treatment of 15 




6.3.2 Exogenous aggrecan does not alter cell adhesion strength 
In chapter 4, exogenous aggrecan was shown to increase the PCM thickness around the 
cells and reduce the pore size of the cell coat. Here we investigate whether exogenous aggrecan 
diffuses under the cell and impacts adhesion strength. Although the experiment was only done 
once, the adhesion strength of RCJ-P treated with exogenous aggrecan, 363.79 ± 40.25 dyne/cm2 
(N=3), was similar to the control cells, 370.33 ± 37.89 dyne/cm2 (N=12). The same experiment 
was repeated on another type of cell, the breast cancer cell line MDA-MB-231, which yielded 
similar results. The experiment on the breast cancer cell was also done only one time, and the 
adhesion strength of the control and exogenous aggrecan treated cells were 240.00 ± 7.88 
dyne/cm2 (N=8) and 243.62 dyne/cm2 (N=1) respectively. Complementary fluorescence studies 
to check if fluorescently-labeled exogenous ACAN permeated below the cell surface of RCJ-P 
cells suggested that it does not. 
As a side note, these experiments are an interesting control of the impact of swollen PCM 




extent of the cell, could impact that hydrodynamic forces on the cells. Yet, as one might expect, 
this extremely soft, deformable matrix has little impact even when it is more than doubled in its 
extent in these experiments (97).   
 
6.3.3 Efforts to confirm that lectican exists at the cell-substrate interface  
The increased adhesion strength after digestion of CS inspired us to confirm our standing 
assumption, based on the literature, that lecticans are present at the cell-substrate interface in 
PCM-rich cells (37). Originally we were convinced that since the PCM is extended on our model 
cell lines, there must be lectican like aggrecan on the RCJ-P and versican on the prostate cancer 
cells at the interface as well. Lectican is one of the main components of the pericellular matrix, 
and the large size of lectican (average 80 x 300 nm with a hydrodynamic radius of ~150 nm (168)) 
can generate the gap under the cells and exert the repulsive force between cell and substrate. 
Various efforts were made to investigate/confirm the presence of lecticans, but no conclusive 
evidence was found for the presence of lecticans under cells.  The various strategies employed 
are summarized here: 
 
6.3.3.1 Antibody labeling of CS with CS-56 
The anti-chondroitin sulfate antibody, CS-56, was used on fixed RCJ-P and PC3 cells. But 
there was no significant fluorescent signal visible at the cell-substrate interface. The antibodies 
were also tested to living cells. The antibodies seemed to be internalized by the cells so the 
aggregation of the CS-56 outside of cell membrane could not be distinguished from the ones 
inside the cells. To test our labeling process, PC3 cells were first treated with exogenous ACAN, 




the PCM with ACAN, all the CS-56 labeling appeared to be on the glass surface. Still, no 
fluorescence was visible under the cells. 
6.3.3.2 Electrostatic labeling with fluorescently-labeled positive proteins (histones) 
In Ch. 4, evidence of fluorescent histone binding to the GAG side chains of the lectican was 
reported. Histone is a small molecule with a size less than 20 kDa. Fluorescent BSA can access 
to space under the cells (data not shown) with its size larger than 60 kDa so histone should be 
able to get under the cell with its small size. However, after incubating RCJ-P cells with fluorescent 
histone, the aggregation of histone could be seen inside the PCM around the cells but with no 
sign of histone concentration could be found anywhere under the cells. In hindsight, this result 
that histone is in the extended PCM but not under the cell, could arise from the surrounding PCM 
capturing the majority of the histone and leaving little left to diffuse under the cell. A similar effect 
could occur for the antibodies as well. This should be further investigated. 
 
6.3.3.3 RICM shows topography not flatten after CS digestion 
In the RICM microscope used in this work, the range of the interference pattern from dark 
to bright is about 135 nm. The interference pattern’s shade will go from dark, when the cell 
membrane is in contact with the substrate, to the brightest, when the distance between cell and 
substrate is about 135 nm, and then go back down to dark again. The average size of a fully 
extended lectican is about ~80 x 300 nm (or ~200 nm diameter as a globule), which is large in 
our RICM setting. Even the change of distance on the short side of a single cylindrical CSPG will 
drastically alter the interference fringes in the RICM images.  
In chapter 5, we reported that the ventral topography of cells flattens after HA digestion, 
and the cell membrane moves further towards the substrate. Comparing to the 94% rate of 





Figure 6.2: The average pixel intensity standard deviation before and after enzyme treatment for 




topography only on 1/3 of the 87 RCJ-P cells imaged. The quantitative analysis (method 
described in section 5.3.3) of the RICM images showed the standard deviation of the pixel 
intensity histogram before and after ChABC treatment for 20 minutes decreased an average 53.30 
from 442.66 ± 9.89 to 389.36 ± 13.31. This is half of the standard deviation decrease from the 
bovine HAdase treatment, which was 114.13 (see Figure 6.2). It shows that ChABC did smooth 
out the topography under the cell, but it is not as effectively as the bacterial HAdase. This 
experiment was performed only on the RCJ-P cell line. These null results of locating lectican 
under the cells combined with the observation that the majority of cells maintained a similar ventral 
gap after ChABC treatment, suggests that lectican may not be present under the cells. This is 
further supported by the observation that the ventral gap decreases rapidly after HA digestion 
with HAdase; yet if bottlebrushes are present, it would require that the lecticans either rapidly 
diffuse out from under the cell or else be immediately endocytosed or degraded by the cell. The 





6.3.3.4 Indirect evidence: Aggrecanase 
To investigate if lectican is under the cells and its effect on cell adhesion, we planned to 
measure the adhesion strength of cells treated with aggrecanase, ADAM-TS4, which targets and 
cleaves the protein backbone of the lectican, aggrecan. Although ChABC digesting the side 
chains of the lectican collapses the PCM around it, it may also impact other non-PCM aspects of 
the cell, since CS is a common GAG appended during glycosylation of numerous proteins, 
including for example, CD44.  
Digesting the protein backbone with aggrecanase was hence an alternative route to 
measure the effect of lectican on cell adhesion. However, the functionality of the aggrecanase 
was not realized despites numerous trials on living cells including RCJ-P and PC3. The thickness 
of the PCM was not altered after incubation with aggrecanase, an indication of its failure. One 
possible explanation is that since the cells secret lectican into the media, there might be just too 
high a lectican concentration around the cells that the aggrecanase could not reach the PCM. 
However, replacing with fresh media before adding aggrecanase still presented null result. The 
next thing to do after would be putting the enzyme into exogenous aggrecan solution. A size 
measurement before and after the enzyme should reveal if the aggrecanase work or not. 
 
6.4 Discussion 
6.4.1 CS effect on adhesion also shown in HAdase results 
The effect of CS on the adhesion strength might also be reflected in the HAdase 
experiments. Bovine HAdase, which degrades CS at a higher rate than bacterial HAdase (24), 
causes a higher adhesion strength increase than the bacterial counterpart. The additional 




HAdase because GFPn labeling of the interfacial HA matrix decreased by similar amount (~80% 
of original intensity) after both HAdase treatments. 
 
6.4.2 PCM composition differences between cell types shown in adhesion change 
Now, let’s compare the adhesion strength increase between the two cell types, RCJ-P and 
PC3. On RCJ-P, ChABC increased the adhesion strength more than both bacterial and bovine 
HAdase for both incubation durations (see table 6.1). The increase by ChABC is close to that of 
bovine HAdase, within 5% of control adhesion value, but more than three times higher than that 
of bacterial HAdase. However, on PC3 cells, the adhesion strength increase by ChABC is larger 
than bacterial HAdase but smaller than bovine HAdase. The trend is consistent in both enzyme 
incubation durations. The differences between the two cell types could stem from different PCM 
compositions. RCJ-P has a substantial amount of lectican in the PCM (113), so when the cells 
are treated with ChABC and bovine HAdase, which both degrade CS more efficiently than 
bacterial HAdase, the adhesion strength increases more. On the other hand, the lack of lecticans 
on PC3 cells shown by Ricciardelli and et al. in 2007 provides a possible explanation for the 
adhesion strength increase by bovine HAdase being higher than that by ChABC (41). 
 
6.4.3 Possible source of interfacial CS on HA receptor 
  Chondroitin sulfate binds to the HA receptor, CD44 (169). CS side chain modifying 
invariant chain, which is a non-polymorphic glycoprotein, is also shown to bind directly to CD44, 
and enhance signaling or adhesion of the cells (170). CD44 is shown to affect cell adhesion by 
not only binding to the extracellular matrix through HA and ligands, it also mediates signaling of 
receptors tyrosine kinases. Connected to actin cytoskeleton, signaling from CD44 can propagate 




might not be on the interfacial lecticans but on the HA receptors and it altered the cell adhesion 
via signaling, or some combination of those two effects. 
 
6.5 Conclusion and Outlook 
These studies provide quantitative illustration of the adhesion strength change by ChABC 
enzyme. The cell adhesion strength increases significantly after ChABC enzyme treatment. The 
source of the adhesion change was speculated to be the presence of large, negatively charged 
lecticans at the cell-substrate interface and pose a repulsive force to the cells. Various efforts to 
visualize the presence of lecticans under the cell are documented here, including antibody 
staining, electrostatic binding with fluorescent histone, investigation of space at the cell-substrate 
interface, and digestion by aggrecanase, a lectican protein backbone specific enzyme. But no 
evidence of the lectican presence was confirmed. This suggests that the change in adhesion 
strength results from digestion of CS elsewhere at the cell interface, likely that on a cell receptor 
which leads to signaling and change in adhesion. The most likely receptor, identified at this point 
– based on our limited knowledge so far, is CD44. CD44 is glycosylated with CS and is involved 








PCM Characterization on Migrating Cell 
 
7.1 Overview 
The uneven accumulation of the PCM around cells during migration affecting the cell 
adhesion has long been an inspiration for our work on quantifying the physical effect on adhesion 
by the HA polymer matrix. The proposed model of the HA effect on migrating cells is intriguing 
(42). It hypothesizes that more HA at the trailing edge of the migrating cell reduces the adhesion 
comparing to the leading edge, which has less HA presence and creates a gradient of adhesion 
strength to enable the cell to detach at the trailing end, pull itself toward the leading edge and 
move forward.  
As we have made progress on analyzing the simplified scenario of hyaluronan-mediated 
adhesion, we also began to invest in the preliminary assays for future studies focused on HA 
mechanics during cell migration. Most notably, we need a system where cell migration can be 
reproducibly induced under similar conditions such that the PCM around and under the cell can 
be characterized. To date, only crude particle exclusion assays with red blood cells have been 
used to depict the asymmetric PCM on migrating cells; hence the data produced using any of the 
methods introduced here and in the previous work of Louis McLane to characterize the migratory-
PCM would incredibly insightful (97).   
Two methods were pursued. The first is the classic wound healing assay, which was used 
to successfully reproduce asymmetric PCM on migratory cells and to, for the first time, label the 
asymmetric PCM fluorescently. A wound healing assay was used to ensure a directional migration 
of the cells. Otherwise it is hard to distinguish a migrating cell and it may not have a persistent 




on live cells. Reported here is just our preliminary attempt to study the PCM during cell migration. 
The next step would be to have a better control on the cell migration, as for example, is the goal 
of the second approach. The second approach, still under construction and in collaboration with 
an undergraduate, is to generate reproducible protein gradients on surfaces to induce cell 
migration (not presented here but listed for completeness).  
 
7.2 Wound healing assay to generate directional cell migration 
The wound healing assay is one of the earliest developed methods to study directional 
cell migration in vitro (172). This method mimics the cell migration to close the wound in vivo by 
creating an artificial wound in cell layers. RCJ-P cells were first grown for about 48 hours to 
confluency on cover glass to form a monolayer of cells. A gap was then scratched by the tip of a 
pipette tip. Different sizes of pipette tip can be used to create different sizes of gaps. The cells 
were then incubated with the complete culture media in the stage-top incubator controlling the 
temperature at 37°C and CO2 level at 5% and imaged for the next 12 – 24 hours around the gap. 
Automated stage was used to image multiple locations at a fixed rate over the period. Lamp was 
turned off when camera was idle to minimize the phototoxicity damage of the cells.  
The cells migrated collectively. At the edge of the gap, whole lines of cells migrated toward 
the center of the gap together. Although there were some cells moved faster and protrude out of 
the pack, the majority of the cell closed the gap at similar rate. The migration was prominent for 
the first 12 hours, and then the cells were more or less rocking around the same position. The 
progression of the cell front stopped. It wasn’t until more culture media was added in, the cells 
began to migrate toward the gap center again. The second round of migration stopped after about 










usual experiments, used up all the nutrients in the solution and stopped migration. After the fresh 
media and more nutrient were in the surrounding, cells continued to migrate again. 
From past experience, phototoxicity prevents cells from proliferating. However, in our 
setting that turns off the lamp between imaging and images total of 12 positions every 20 minutes 
for about 2.5 seconds at a time, the cells were healthy and dividing. Not only the cells divided at 
the edge of the gap, where there was more room, they also divided among the tightly packed 
region. From the regions imaged, similar proliferation rates were observed at the edge of the gap 
or in the confluent areas. 
 
7.3 Asymmetric PCM on migrating cells 
GFPn was used to visualize the PCM around cells. 22 hours after the creation of the 
wound, GFPn was then added to the culture media for imaging on confocal microscope with on-





Figure 7.2: GFPn labeled asymmetric HA on migrating RCJ-P, 3 μm above glass. Cell migrating 
towards lower right corner, as indicated with yellow arrow, showing more HA accumulation at the 




On the individual cells that broke out of the collective cell formation, the PCM can be 
imaged without interference from other cells. For those cells, we were able to confirm for the first 
time in the Curtis lab that the PCM distribution on migrating cells is asymmetric. Knowing the 
direction of the cell migration with wound healing assay, we can point out that more HA 
accumulation appears at the rear end of the cells and less HA at the leading edge of the migrating 
cell, which is comparable to the finding reported by Evanko, et al (42) and a few other (not many) 
reports (173, 174)(Figure 7.2). In Ch.5, we reported that there is a spatial correlation of focal 
adhesions with the gaps between HA patches under the cell. In Figure 7.3b, there were more 
gaps between HA patches at the leading edge of the migrating cells than the rear end. The indirect 
evidence showed more and larger FA appear at the direction of migration under the cells, 





Figure 7.3: (a) GFPn labeled asymmetric HA on migrating RCJ-P cell, 3 μm above glass. Cell 
migrating towards lower right corner, as indicated with yellow arrow. (b) GFPn labeled HA under 




7.4 Conclusion and Outlook 
We have used wound healing assay to initiate and loosely control the direction of cell 
migration. This enabled us to examine the distribution of HA on the cell surface for the first time 
using a fluorescent label. Combining the two observations, accumulation of PCM at the trailing 
edge while more FA presence at the leading edge of the migration cells, we have provided visual 
evidence for the hypothesis that cells utilize various amount of HA to facilitate a gradient of 
adhesion strength to the substrate during cell migration.  
Developing methods to better control the cell migration are currently being investigated, and will 
help provide a cleaner experiment and a higher result throughput. Our belief is that the above 
results combined with our studies on the impact of HA matrix on adhesion will bring about a 






Conclusion and Outlook 
 
Pericellular matrix (PCM) has been neglected despite its apparently crucial role in many 
physiological processes. In this work, we developed novel biophysical tools to improve the 
examination of the PCM microstructure. The nondestructive technique, qPEA, provides the first 
quantitative evidence of the pore size in the PCM varies with the distance to cell surface. The 
passivated fluorescent microspheres of the qPEA demonstrates that even without the electrostatic 
repulsion or chemical interactions that are expected to occur in the highly negatively charged 
matrix due to bottlebrush CSPGs, access to the cell surface is affected by the cell coat 
microstructure. This has direct implications for cell defense against viral and bacterial infections, 
exosome biology, and drug delivery applications. 
We demonstrated that the accessibility of the cell can be modified with exogenous 
bottlebrush CSPGs. Studies shown in chapter 4 provide quantitative illustrations of how changes 
in bottlebrush proteoglycan concentration in the PCM can affect the transport of nanoparticles to 
the cell surface as well as the sequestration of positively charged molecules. Fluorescent labeling 
of the bottlebrush proteoglycans shows that diffusion of the bottlebrushes themselves still occurs 
through saturated pericellular matrix despite the sizable dimensions of the molecule and its 
negative charge. Evidence for the sparse population of native bottlebrushes points to the 
possibility for cells to use surface-tethered proteoglycans to control native cell surface 
accessibility or to concentrate and sequester biomolecules like growth factors. Mechanics could 
be altered this way as well. For the cell types studied in this research, a special regime exists 
where the PCM appears fully stretched, but the porosity and molecular interactions can be tuned 




 In Chapters 5 and 6, we tested the hypothesis that HA-rich pericellular matrix plays an 
mechanical role in orchestrating the cell adhesion, which is crucial in many physiological 
processes including cell migration and proliferation. Although there are many other areas of study 
in cell adhesion, such as signaling pathway and focal adhesion (FA) structure, the role of the long 
sugar polymer matrix at the interface of cell and adhesion substrate can be not ignored (88). In 
this work we provide evidence of the spatial anti-correlation of FA and the interfacial HA matrix 
and show those HA matrix creates uneven topography under cells. Previous studies showed that 
the distance created by ‘bulky polysaccharides’ can decrease the receptor-ligand interaction by 
altering kinetics (175, 176). We examined a complementary route by which hyaluronan could 
impact cell adhesion, namely that the interfacial HA matrix exerts a direct repulsive force between 
the cell and substrate, weakening the adhesion of the cell to the substrate. Using the 
hydrodynamic spinning disk apparatus, we quantitatively documented the impact on the adhesion 
strength of RCJ-P and PC3 cells before and after HA matrix degradation. After HAdase or ChABC 
enzymes treatments, the adhesion strength of cells with HA matrix increased significantly, while 
cells without HA matrix remain the same. This result demonstrated the adhesion strength increase 
is result from HA removal and not an artifact caused by the enzyme. However, the mechanism of 
the adhesion strength alteration by the HA matrix is still unclear. Our analysis is based on several 
assumptions we tried to address in the chapters, but the repulsive interfacial HA matrix hypothesis 
still needs to be examined further. 
 In addition, we combine a convenient and popular method, wound healing assay, with our 
techniques to provide the first direct visualization of the asymmetric hyaluronan distribution of the 
PCM around migrating cells. Our work provides the visual evidence for the hypothesis that cells 





Our efforts in the lab throughout the duration of this thesis have been focused on 
characterizing the physical impact of PCM on the two most obvious possible processes that the 
cell coat might have (i) passage of objects to and from the surface and (ii) the mechanics of cell 
adhesion. As summarized above, we have made some good progress in a widely uncharted 
territory. Moving forward, there is much to do and as we have become more familiar and 
experienced with the biology of a structure that few appreciate exists; and as we have 
developed tools to study the PCM, we are now in the exciting position to make significant 
headway. The topics to be pursued are numerous. Each thread of investigation listed below has 
some fundamental biophysical research question related combined with an important question 
or application in biology, medicine or bioengineering. 
We have some immediate follow-up for the work presented in this thesis. In chapter 4, we 
demonstrated that the small and positively charged molecule, histone, concentrated and attached 
to the CSPG. Our work with histone was a proof of principle showing that PCM can sequester 
positive charged molecules. Since the main goal has always been studying the sequestration of 
growth factor inside PCM, immediately relevant are follow up studies examining growth factor 
sequestration to the PCM, investigation of its release, and its possible effects on cell. For example, 
after fluorescently labeling the BMP-2, looking at whether the growth factor is sequestered and 
concentrated to high enough concentrations to drive differentiation of stem cells would be an 
excellent example of how PCM can be utilized by cells as a molecular reservoir.  
In chapter 5 and chapter 6, depleting the interfacial HA and CS increases the cell adhesion 
strength. The enzyme treatment is not the ideal treatment to study the mechanical effect of HA 
matrix on adhesion because of its various possible side effects discussed in the chapters. An 
improved method to control the HA presence is varying the expression level of HA synthases 
(HAS). We will use a well-established method by our collaborator Dr. Heldin, who agreed to share 




regulate HAS using siRNA following protocols developed and tested in Dr. Heldin’s lab (80). 
Comparing the adhesion strength of the increased amount of HA synthesis with the control cells 
can cleanly distinguish the mechanical effect of the HA matrix on adhesion events.  
While our work presented here was performed on different cell types, mainly on rat’s 
chondrocytes and human prostate cancer cells, we still want to broaden our base and bring our 
research to other related cell lines. Human breast cancer cell, Hs578T, is our target for its impact 
on human disease well-being. The advantage of this cell line also includes its popularity and the 
many researches related to hyaluronan have been done (58, 80, 177–179). As mentioned 
previously, we have started the preliminary investigation for characterization of the PCM with 
PEA, showing that an average thickness of 5.79 ± 0.74 μm (N=41) in chapter 3.3.1. Fluorescent 
paxillin transfection has also been done on the breast cancer cell showing spatial anti-correlation 
between the interfacial HA and FAs (Figure 5.5). However, to move on to the next step of 
quantitative adhesion strength measurement by spinning disk apparatus, we need to device 
micropatterned surfaces to control the irregular cell shape for the quality insurance of the 
adhesion strength measurement. We have started putting together micro-contact printing method 
(180). The procedure involves making PDMS stamps with positive micropatterns of our choosing 
with protein attached, transferring the patterned protein onto cover glass and then passivating the 
un-patterned surfaces with polyethylene glycol compound to prevent cell attachment to the un-
patterned locations. The stamps have been made but the patterning process suitable for cell 
adhesion is still under optimization. After the optimization is done, adhesion strength of the breast 
cancer cells with various HA matrix conditions can be measured with a well-controlled cell shape 
and area. 
Another direct follow up for the work presented in this thesis is the cell migration presented 
in chapter 7. The wound healing assay can incentivize the cells to migrate in a certain direction 




PCM status during migration because of the concerted movement of the cells during such assay. 
It was hard to study PCM on individual cell because they are packed close together. Other 
methods are considered including microfluidic (184), chemotaxis (185), and the one currently 
being pursued in our lab, a gradient of ligand concentration driving the cells toward more 
concentrated area. A more controlled cell migration can potentially allow us to monitor the PCM 
during migration on single cells and elucidate its effect. 
One of our recent related work on cell adhesion has been done in collaboration with Dr. 
Salaita in Emory University. The Salaita group created a protein based molecular tension sensor 
to measure the tension on individual integrin bond (186). A changeable spring-like molecule 
connects integrin binding ligand with a fluorescent dye to a nano-particle fluorescence quencher 
bound to the substrate. When relaxed, the fluorescent dye is close to the nano-particle and the 
fluorescent intensity is low undergoing resonance energy transfer (RET). After cell attaching to 
the ligand on the other end of the sensor stretches the spring-like molecule, the distance between 
the dye and quencher increases to produce higher fluorescent intensity. The fluorescent intensity 
varies with the distance between the dye and the nano-particle quencher on the surface denoting 
the different tension on the integrin. Molecules with various stiffness can be used as the probe of 
the tension sensor.  
In our preliminary experiment, different molecules were tested with the cell lines studied, 
including the 27th immunoglobulin domain of cardiac titin proteins, DNA hairpin and polyethylene 
glycol (PEG) polymer. The most probable unfolding force for the probes are ~80-200 pN for the 
titin sensor, ~4-50 pN for DNA denaturation and ~2-6 pN with the polymer probe stretching. Trials 
with the RCJ-P and PC3 cells even on the polymer probe showed the contraction force was too 
weak to produce significant fluorescent signal from the sensor. The breast cancer cell, Hs578T, 




the cell line is strong enough to denature the strongest titin sensor and exhibit clear signal from 
the tension sensor. 
Our preliminary experiment showed the average fluorescent intensity from the sensor 
decreases by about 10% (N=14) after bacterial HAdase digested the HA matrix on the breast 
cancer cell, Hs578T. One would naively think that means the tension on the integrin bonds is 
smaller after the HA matrix depletion, which corresponds to our theory that interfacial HA exerts 
a repulsive force between cell and substrate. The detail experimental setup and account will be 
in Appendix A. However, more studies need to be done before conclusion is made. 
The goal of this work was to study the structure and mechanics of the pericellular matrix 
using various biophysical tools. The insights gained into the PCM microstructure build the 
knowledge base for future studies on the matrix and a wide variety of the physiological processes 
the matrix influence. A tighter focus of the effect of PCM on the adhesion events provides an 
alternative direction for the elucidation of the matrix mechanics complementing the signal pathway 
approach. We hope our work will inspire further discoveries on the PCM and help improve the 
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